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Foreword 
 
The evaluation of research and doctoral training is being carried out in the years 2010–2012 and will end in 
2012. The steering group appointed by the Rector in January 2010 set the conditions for participating in 
the evaluation and prepared the Terms of Reference to present the evaluation procedure and criteria. The 
publications and other scientific activities included in the evaluation covered the years 2005–2010. 
The participating unit in the evaluation was defined as a Researcher Community (RC). To obtain a 
critical mass with university-level impact, the number of members was set to range from 20 to 120. The 
RCs were required to contain researchers in all stages of their research career, from doctoral students to 
principal investigators (PIs). All in all, 136 Researcher Communities participated in this voluntary 
evaluation, 5857 persons in total, of whom 1131 were principal investigators. PIs were allowed to 
participate in two communities in certain cases, and 72 of them used this opportunity and participated in 
two RCs. 
This evaluation enabled researchers to define RCs from the “bottom up” and across disciplines. The aim 
of the evaluation was not to assess individual performance but a community with shared aims and 
researcher-training activities. The RCs were able to choose among five different categories that 
characterised the status and main aims of their research. The steering group considered the process of 
applying to participate in the evaluation to be important, which lead to the establishment of these 
categories. In addition, providing a service for the RCs to enable them to benchmark their research at the 
global level was a main goal of the evaluation. 
The data for the evaluation consisted of the RCs’ answers to evaluation questions on supplied e-forms 
and a compilation extracted from the TUHAT – Research Information System (RIS) on 12 April 2011. The 
compilation covered scientific and other publications as well as certain areas of scientific activities. During 
the process, the RCs were asked to check the list of publications and other scientific activities and make 
corrections if needed. These TUHAT compilations are public and available on the evaluation project sites 
of each RC in the TUHAT-RIS. 
In addition to the e-form and TUHAT compilation, University of Leiden (CWTS) carried out bibliometric 
analyses from the articles included in the Web of Science (WoS). This was done on University and RC 
levels. In cases where the publication forums of the RC were clearly not represented by the WoS data, the 
Library of the University of Helsinki conducted a separate analysis of the publications. This was done for 
66 RCs representing the humanities and social sciences. 
The evaluation office also carried out an enquiry targeted to the supervisors and PhD candidates about 
the organisation of doctoral studies at the University of Helsinki. This and other documents describing the 
University and the Finnish higher education system were provided to the panellists. 
The panel feedback for each RC is unique and presented as an entity. The first collective evaluation 
reports available for the whole panel were prepared in July–August 2011. The reports were accessible to all 
panel members via the electronic evaluation platform in August. Scoring from 1 to 5 was used to 
complement written feedback in association with evaluation questions 1–4 (scientific focus and quality, 
doctoral training, societal impact, cooperation) and in addition to the category evaluating the fitness for 
participation in the evaluation. Panellists used the international level as a point of comparison in the 
evaluation. Scoring was not expected to go along with a preset deviation. 
Each of the draft reports were discussed and dealt with by the panel in meetings in Helsinki (from 11 
September to 13 September or from 18 September to 20 September 2011). In these meetings the panels 
also examined the deviations among the scores and finalised the draft reports together. 
The current RC-specific report deals shortly with the background of the evaluation and the terms of 
participation. The main evaluation feedback is provided in the evaluation report, organised according to 
the evaluation questions. The original material provided by the RCs for the panellists has been attached to 
these documents. 
 
 
 
 
 
 
 
 
 
On behalf of the evaluation steering group and office, I sincerely wish to thank you warmly for your 
participation in this evaluation. The effort you made in submitting the data to TUHAT-RIS is gratefully 
acknowledged by the University. We wish that you find this panel feedback useful in many ways. The 
bibliometric profiles may open a new view on your publication forums and provide a perspective for 
discussion on your choice of forums. We especially hope that this evaluation report will help you in setting 
the future goals of your research. 
 
Johanna Björkroth 
Vice-Rector 
Chair of the Steering Group of the Evaluation 
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CHAIR 
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Karolinska Institute, Sweden 
 
VICE-CHAIR 
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providing the evaluation project with the updated information from TUHAT-RIS. 
The TUHAT office assisted in mapping the publications with CWTS/University of 
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MA Liisa Ekebom, Assisting Officer, served in TUHAT-RIS updating the 
publications for the evaluation. She also assisted the UH/Library analyses. 
BA Liisa Jäppinen, Assisting Officer, served in TUHAT-RIS updating the 
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HELSINKI UNIVERSITY LIBRARY 
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Acronyms and abbreviations applied in the report 
 
External competitive funding 
AF – Academy of Finland 
TEKES - Finnish Funding Agency for Technology and Innovation  
EU - European Union 
ERC - European Research Council 
International and national foundations 
FP7/6 etc. /Framework Programmes/Funding of European Commission 
 
Evaluation marks 
Outstanding (5) 
Excellent  (4) 
Very Good  (3) 
Good  (2) 
Sufficient  (1) 
 
Abbreviations of Bibliometric Indicators 
P - Number of publications 
TCS – Total number of citations 
MCS - Number of citations per publication, excluding self-citations 
PNC - Percentage of uncited publications 
MNCS - Field-normalized number of citations per publication 
MNJS - Field-normalized average journal impact 
THCP10 - Field-normalized proportion highly cited publications (top 10%) 
INT_COV - Internal coverage, the average amount of references covered by the WoS 
WoS – Thomson Reuters Web of Science Databases 
 
Participation category 
Category 1. The research of the participating community represents the international cutting edge in its 
field. 
Category 2. The research of the participating community is of high quality, but the community in its 
present composition has yet to achieve strong international recognition or a clear break-through. 
Category 3. The research of the participating community is distinct from mainstream research, and the 
special features of the research tradition in the field must be considered in the evaluation. 
Category 4. The research of the participating community represents an innovative opening. 
Category 5. The research of the participating community has a highly significant societal impact. 
 
Research focus areas of the University of Helsinki 
Focus area 1: The basic structure, materials and natural resources of the physical world 
Focus area 2: The basic structure of life 
Focus area 3: The changing environment – clean water 
Focus area 4: The thinking and learning human being 
Focus area 5: Welfare and safety 
Focus area 6: Clinical research 
Focus area 7: Precise reasoning 
Focus area 8: Language and culture 
Focus area 9: Social justice 
Focus area 10: Globalisation and social change 
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1 Introduction to the Evaluation 
1.1 RC-specific evaluation reports 
The participants in the evaluation of research and doctoral training were Researcher Communities 
(hereafter referred to as the RC). The RC refers to the group of researchers who registered together in the 
evaluation of their research and doctoral training. Preconditions in forming RCs were stated in the 
Guidelines for the Participating Researcher Communities. The RCs defined themselves whether their 
compositions should be considered well-established or new. 
It is essential to emphasise that the evaluation combines both meta-evaluation1 and traditional 
research assessment exercise and its focus is both on the research outcomes and procedures associated 
with research and doctoral training. The approach to the evaluation is enhancement-led where self-
evaluation constituted the main information. The answers to the evaluation questions formed together 
with the information of publications and other scientific activities an entity that was to be reviewed as a 
whole. 
The present evaluation recognizes and justifies the diversity of research practices and publication 
traditions. Traditional Research Assessment Exercises do not necessarily value high quality research with 
low volumes or research distinct from mainstream research. It is challenging to expose the diversity of 
research to fair comparison. To understand the essence of different research practices and to do justice to 
their diversity was one of the main challenges of the present evaluation method. Understanding the 
divergent starting points of the RCs demanded sensitivity from the evaluators. 
1.2 Aims and objectives in the evaluation 
The aims of the evaluation are as follows: 
 to improve the level of research and doctoral training at the University of Helsinki and to raise 
their international profile in accordance with the University’s strategic policies. The improvement 
of doctoral training should be compared to the University’s policy.2 
 to enhance the research conducted at the University by taking into account the diversity, 
originality, multidisciplinary nature, success and field-specificity, 
 to recognize the conditions and prerequisites under which excellent, original and high-impact 
research is carried out, 
 to offer the academic community the opportunity to receive topical and versatile international 
peer feedback, 
 to better recognize the University’s research potential. 
 to exploit the University’s TUHAT research information system to enable transparency of 
publishing activities and in the production of reliable, comparable data. 
1.3 Evaluation method 
The evaluation can be considered as an enhancement-led evaluation. Instead of ranking, the main aim is to 
provide useful information for the enhancement of research and doctoral training of the participating RCs. 
The comparison should take into account each field of science and acknowledge their special character. 
                                                                
1 The panellists did not read research reports or abstracts but instead, they evaluated answers to the evaluation 
questions, tables and compilations of publications, other scientific activities, bibliometrics or comparable analyses. 
2
 Policies on doctoral degrees and other postgraduate degrees at the University of Helsinki.  
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The comparison produced information about the present status and factors that have lead to success. Also 
challenges in the operations and outcomes were recognized. 
The evaluation approach has been designed to recognize better the significance and specific nature of 
researcher communities and research areas in the multidisciplinary top-level university. Furthermore, one 
of the aims of the evaluation is to bring to light those evaluation aspects that differ from the prevalent 
ones. Thus the views of various fields of research can be described and research arising from various 
starting points understood better. The doctoral training is integrated into the evaluation as a natural 
component related to research. Operational processes of doctoral training are being examined in the 
evaluation. 
 
Five stages of the evaluation method were: 
1. Registration – Stage 1 
2. Self-evaluation – Stage 2 
3. TUHAT3 compilations on publications and other scientific activities4 
4. External evaluation 
5. Public reporting 
1.4 Implementation of the external evaluation 
Five Evaluation Panels 
Five evaluation panels consisted of independent, renowned and highly respected experts. The main 
domains of the panels are: 
1. biological, agricultural and veterinary sciences 
2. medicine, biomedicine and health sciences 
3. natural sciences 
4. humanities 
5. social sciences 
The University invited 10 renowned scientists to act as chairs or vice-chairs of the five panels based on 
the suggestions of faculties and independent institutes. Besides leading the work of the panel, an 
additional role of the chairs was to discuss with other panel chairs in order to adopt a broadly similar 
approach. The panel chairs and vice-chairs had a pre-meeting on 27 May 2011 in Amsterdam. 
The panel compositions were nominated by the Rector of the University 27 April 2011. The participating 
RCs suggested the panel members. The total number of panel members was 50. The reason for a smaller 
number of panellists as compared to the previous evaluations was the character of the evaluation as a 
meta-evaluation. The panellists did not read research reports or abstracts but instead, they evaluated 
answers to the evaluation questions, tables and compilations of publications, other scientific activities, 
bibliometrics and comparable analyses. 
 
The panel meetings were held in Helsinki: 
 On 11–13 September 2011: (1) biological, agricultural and veterinary sciences, (2) medicine, 
biomedicine and health sciences and (3) natural sciences.  
 On 18–20 September 2011: (4) humanities and (5) social sciences. 
  
                                                                
3 TUHAT (acronym) of Research Information System (RIS) of the University of Helsinki 
4 Supervision of thesis, prizes and awards, editorial work and peer reviews, participation in committees, boards and 
networks and public appearances. 
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1.5 Evaluation material 
The main material in the evaluation was the RCs’ self-evaluations that were qualitative in character and 
allowed the RCs to choose what was important to mention or emphasise and what was left unmentioned. 
The present evaluation is exceptional at least in the Finnish context because it is based on both the 
evaluation documentation (self-evaluation questions, publications and other scientific activities) and the 
bibliometric reports. All documents were delivered to the panellists for examination. 
Traditional bibliometrics can be reasonably done mainly in medicine, biosciences and natural sciences 
when using the Web of Science database, for example. Bibliometrics, provided by CWTS/The Centre for 
Science and Technology Studies, University of Leiden, cover only the publications that include WoS 
identification in the TUHAT-RIS. 
Traditional bibliometrics are seldom relevant in humanities and social sciences because the 
international comparable databases do not store every type of high quality research publications, such as 
books and monographs and scientific journals in other languages than English. The Helsinki University 
Library has done analysis to the RCs, if their publications were not well represented in the Web of Science 
databases (RCs should have at least 50 publications and internal coverage of publications more than 40%) 
– it meant 58 RCs. The bibliometric material for the evaluation panels was available in June 2011. The RC-
specific bibliometric reports are attached at the end of each report. 
The panels were provided with the evaluation material and all other necessary background information, 
such as the basic information about the University of Helsinki and the Finnish higher education system. 
 
Evaluation material 
1. Registration documents of the RCs for the background information 
2. Self evaluation material – answers to the evaluation questions 
3. Publications and other scientific activities based on the TUHAT RIS: 
3.1. statistics of publications 
3.2. list of publications 
3.3. statistics of other scientific activities 
3.4. list of other scientific activities 
4. Bibliometrics and comparable analyses: 
4.1. Analyses of publications based on the verification of TUHAT-RIS publications with the Web 
of Science publications (CWTS/University of Leiden) 
4.2. Publication statistics analysed by the Helsinki University Library - mainly for humanities and 
social sciences 
5. University level survey on doctoral training (August 2011) 
6. University level analysis on publications 2005–2010 (August 2011) provided by CWTS/University 
of Leiden 
 
Background material 
 
University of Helsinki 
- Basic information about the University of the Helsinki 
- The structure of doctoral training at the University of Helsinki 
- Previous evaluations of research at the University of Helsinki – links to the reports: 1998 and 2005 
 
The Finnish Universities/Research Institutes 
- Finnish University system 
- Evaluation of the Finnish National Innovation System 
- The State and Quality of Scientific Research in Finland. Publication of the Academy of Finland 
9/09. 
 
The evaluation panels were provided also with other relevant material on request before the meetings in 
Helsinki. 
8 
 
1.6 Evaluation questions and material 
The participating RCs answered the following evaluation questions which are presented according to the 
evaluation form. In addition, TUHAT RIS was used to provide the additional material as explained. For 
giving the feedback to the RCs, the panellists received the evaluation feedback form constructed in line 
with the evaluation questions: 
 
1. Focus and quality of the RC’s research 
 Description of 
- the RC’s research focus. 
- the quality of the RC’s research (incl. key research questions and results) 
- the scientific significance of the RC’s research in the research field(s) 
 Identification of the ways to strengthen the focus and improve the quality of the RC’s research 
The additional material: TUHAT compilation of the RC’s publications, analysis of the RC’s publications data 
(provided by University of Leiden and the Helsinki University Library) 
A written feedback from the aspects of: scientific quality, scientific significance, societal impact, 
innovativeness 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
 
2. Practises and quality of doctoral training 
 Organising of the doctoral training in the RC. Description of the RC’s principles for: 
- recruitment and selection of doctoral candidates 
- supervision of doctoral candidates 
- collaboration with faculties, departments/institutes, and potential graduate schools/doctoral 
programmes 
- good practises and quality assurance in doctoral training 
- assuring of good career perspectives for the doctoral candidates/fresh doctorates 
 Identification of the RC’s strengths and challenges related to the practises and quality of doctoral 
training, and the actions planned for their development. 
The additional material: TUHAT compilation of the RC’s other scientific activities/supervision of doctoral 
dissertations 
A written feedback from the aspects of: processes and good practices related to leadership and 
management 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
 
3. The societal impact of research and doctoral training 
 Description on how the RC interacts with and contributes to the society (collaboration with 
public, private and/or 3rd sector). 
 Identification of the ways to strengthen the societal impact of the RC’s research and doctoral 
training. 
The additional material: TUHAT compilation of the RC’s other scientific activities. 
A written feedback from the aspects of: societal impact, national and international collaboration, 
innovativeness 
 
  Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
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4. International and national (incl. intersectoral) research collaboration and researcher mobility 
 Description of  
- the RC’s research collaborations and joint doctoral training activities 
- how the RC has promoted researcher mobility 
 Identification of the RC’s strengths and challenges related to research collaboration and 
researcher mobility, and the actions planned for their development. 
A written feedback from the aspects of: scientific quality, national and international collaboration 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
 
5. Operational conditions  
 Description of the operational conditions in the RC’s research environment (e.g. research 
infrastructure, balance between research and teaching duties). 
 Identification of the RC’s strengths and challenges related to operational conditions, and the 
actions planned for their development. 
A written feedback from the aspects of: processes and good practices related to leadership and 
management 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
6. Leadership and management in the researcher community 
 Description of 
- the execution and processes of leadership in the RC 
- how the management-related responsibilities and roles are distributed in the RC 
- how the leadership- and management-related processes support 
- high quality research 
- collaboration between principal investigators and other researchers in the RC 
the RC’s research focus 
- strengthening of the RC’s know-how 
 Identification of the RC’s strengths and challenges related to leadership and management, and 
the actions planned for developing the processes 
 
7. External competitive funding of the RC 
 The RCs were asked to provide information of such external competitive funding, where: 
- the funding decisions have been made during 1.1.2005-31.12.2010, and 
- the administrator of the funding is/has been the University of Helsinki 
 On the e-form the RCs were asked to provide: 
1) The relevant funding source(s) from a given list (Academy of Finland/Research Council, TEKES/The 
Finnish Funding Agency for Technology and Innovation , EU, ERC, foundations, other national funding 
organisations, other international funding organisations), and 
2)The total sum of funding which the organisation in question had decided to allocate to the RCs 
members during 1.1.2005–31.12.2010. 
 
Competitive funding reported in the text is also to be considered when evaluating this point. 
A written feedback from the aspects of: scientific quality, scientific significance, societal impact, 
innovativeness, future significance 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
8. The RC’s strategic action plan for 2011–2013 
 RC’s description of their future perspectives in relation to research and doctoral training. 
A written feedback from the aspects of: scientific quality, scientific significance, societal Impact, processes 
and good practices related to leadership and management, national and international collaboration, 
innovativeness, future significance 
 Strengths 
 Areas of development 
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 Other remarks 
 Recommendations 
 
9. Evaluation of the category of the RC in the context of entity of the evaluation material (1-8) 
 
The RC’s fitness to the chosen participation category 
A written feedback evaluating the RC’s fitness to the chosen participation category  
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
 
10. Short description of how the RC members contributed the compilation of the stage 2 material 
Comments on the compilation of evaluation material 
 
11. How the UH’s focus areas are presented in the RC’s research? 
Comments if applicable 
 
12. RC-specific main recommendations based on the previous questions 1–11 
 
13. RC-specific conclusions 
1.7 Evaluation criteria 
The panellists were expected to give evaluative and analytical feedback to each evaluation question 
according to their aspects in order to describe and justify the quality of the submitted material. In 
addition, the evaluation feedback was asked to be pointed out the level of the performance according to 
the following classifications: 
 outstanding  (5) 
 excellent  (4) 
 very good  (3) 
 good   (2) 
 sufficient  (1) 
 
Evaluation according to the criteria was to be made with thorough consideration of the entire 
evaluation material of the RC in question. Finally, in questions 1-4 and 9, the panellists were expected to 
classify their written feedback into one of the provided levels (the levels included respective descriptions, 
‘criteria’). Some panels used decimals in marks. The descriptive level was interpreted according to the 
integers and not rounding up the decimals by the editors. 
 
Description of criteria levels 
Question 1 – FOCUS AND QUALITY OF THE RC’S RESEARCH 
 
Classification: Criteria (level of procedures and results) 
Outstanding quality of procedures and results (5) 
Outstandingly strong research, also from international perspective. Attracts great international 
interest with a wide impact, including publications in leading journals and/or monographs published 
by leading international publishing houses. The research has world leading qualities. The research 
focus, key research questions scientific significance, societal impact and innovativeness are of 
outstanding quality. 
In cases where the research is of a national character and, in the judgement of the evaluators, should 
remain so, the concepts of ”international attention” or ”international impact” etc. in the grading 
criteria above may be replaced by ”international comparability”. 
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Operations and procedures are of outstanding quality, transparent and shared in the community. The 
improvement of research and other efforts are documented and operations and practices are in 
alignment with the documentation. The ambition to develop the community together is of 
outstanding quality. 
Excellent quality of procedures and results (4) 
Research of excellent quality. Typically published with great impact, also internationally. Without 
doubt, the research has a leading position in its field in Finland. 
Operations and procedures are of excellent quality, transparent and shared in the community. The 
improvement of research and other efforts are documented and operations and practices are to 
large extent in alignment with the documentation. The ambition to develop the community together 
is of excellent quality. 
Very good quality of procedures and results (3) 
The research is of such very good quality that it attracts wide national and international attention. 
Operations and procedures are of very good quality, transparent and shared in the community. The 
improvement of research and other efforts are documented and operations and practices are to 
large extent in alignment with the documentation. The ambition to develop the community together 
is of very good quality. 
Good quality of procedures and results (2) 
Good research attracting mainly national attention but possessing international potential, 
extraordinarily high relevance may motivate good research. 
Operations and procedures are of good quality, shared occasionally in the community. The 
improvement of research and other efforts are occasionally documented and operations and 
practices are to large extent in alignment with the documentation. The ambition to develop the 
community together is of good quality. 
Sufficient quality of procedures and results (1) 
In some cases the research is insufficient and reports do not gain wide circulation or do not have 
national or international attention. Research activities should be revised. 
Operations and procedures are of sufficient quality, shared occasionally in the community. The 
improvement of research and other efforts are occasionally documented and operations and 
practices are to some extent in alignment with the documentation. The ambition to develop the 
community together is of sufficient quality. 
 
Question 2 – DOCTORAL TRAINING 
Question 3 – SOCIETAL IMPACT 
Question 4 – COLLABORATION 
 
Classification: Criteria (level of procedures and results) 
Outstanding quality of procedures and results (5) 
Procedures are of outstanding quality, transparent and shared in the community. The practices and 
quality of doctoral training/societal impact/international and national collaboration/leadership and 
management are documented and operations and practices are in alignment with the 
documentation. The ambition to develop the community together is of outstanding quality. The 
procedures and results are regularly evaluated and the feedback has an effect on the planning. 
Excellent quality of procedures and results (4) 
Procedures are of excellent quality, transparent and shared in the community. The practices and 
quality of doctoral training/societal impact/international and national collaboration/leadership and 
management are documented and operations and practices are to large extent in alignment with the 
documentation. The ambition to develop the community together is of excellent quality. The 
procedures and outcomes are evaluated and the feedback has an effect on the planning. 
Very good quality of procedures and results (3) 
Procedures are of very good quality, transparent and shared in the community. The practices and 
quality of doctoral training/societal impact/international and national collaboration/leadership and 
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management are documented and operations and practices are to large extent in alignment with the 
documentation. The ambition to develop the community together is of very good quality. 
Good quality of procedures and results (2) 
Procedures are of good quality, shared occasionally in the community. The practices and quality of 
doctoral training/societal impact/international and national collaboration/leadership and 
management are documented and operations and practices are to large extent in alignment with the 
documentation. The ambition to develop the community together is of good quality. 
Sufficient quality of procedures and results (1) 
Procedures are of sufficient quality, transparent and shared in the community. The practices and 
quality of doctoral training/societal impact/international and national collaboration/leadership and 
management are occasionally documented and operations and practices are to some extent in 
alignment with the documentation. The ambition to develop the community together is of sufficient 
quality. 
 
Question 9 – CATEGORY 
Participation category – fitness for the category chosen 
The choice and justification for the chosen category below should be reflected in the RC’s responses to the 
evaluation questions 1–8. 
1. The research of the participating community represents the international cutting edge in its field. 
2. The research of the participating community is of high quality, but the community in its present 
composition has yet to achieve strong international recognition or a clear break-through. 
3. The research of the participating community is distinct from mainstream research, and the special 
features of the research tradition in the field must be considered in the evaluation. The research is 
of high quality and has great significance and impact in its field. However, the generally used 
research evaluation methods do not necessarily shed sufficient light on the merits of the 
research.  
4. The research of the participating community represents an innovative opening. A new opening can 
be an innovative combination of research fields, or it can be proven to have a special social, 
national or international demand or other significance. Even if the researcher community in its 
present composition has yet to obtain proof of international success, its members can produce 
convincing evidence of the high level of their previous research. 
5. The research of the participating community has a highly significant societal impact. The 
participating researcher community is able to justify the high social significance of its research. 
The research may relate to national legislation, media visibility or participation in social debate, 
or other activities promoting social development and human welfare. In addition to having 
societal impact, the research must be of a high standard. 
 
An example of outstanding fitness for category choice (5) 5 
The RC’s representation and argumentation for the chosen category were convincing. The RC recognized 
its real capacity and apparent outcomes in a wider context to the research communities. The specific 
character of the RC was well-recognized and well stated in the responses. The RC fitted optimally for the 
category. 
 
 Outstanding  (5) 
 Excellent  (4) 
 Very good  (3) 
 Good   (2) 
 Sufficient  (1) 
The above-mentioned definition of outstanding was only an example in order to assist the panellists in 
the positioning of the classification. There was no exact definition for the category fitness. 
                                                                
5 The panels discussed the category fitness and made the final conclusions of the interpretation of it. 
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1.8 Timetable of the evaluation 
The main timetable of the evaluation: 
1. Registration   November 2010 
2. Submission of self-evaluation materials  January–February 2011 
3. External peer review    May–September 2011 
4. Published reports    March–April 2012 
- University level public report 
- RC specific reports 
 
The entire evaluation was implemented during the university’s strategy period 2010–2012. The preliminary 
results were available for the planning of the following strategy period in late autumn 2011. The evaluation 
reports will be published in March/April 2012. More detailed time schedule is published in the University 
report. 
1.9 Evaluation feedback – consensus of the entire panel 
The panellists evaluated all the RC-specific material before the meetings in Helsinki and mailed the 
draft reports to the evaluation office. The latest interim versions were on-line available to all the panellists 
on the Wiki-sites. In September 2011, in Helsinki the panels discussed the material, revised the first draft 
reports and decided the final numeric evaluation. After the meetings in Helsinki, the panels continued 
working and finalised the reports before the end of November 2011. The final RC-specific reports are the 
consensus of the entire panel. 
The evaluation reports were written by the panels independently. During the editing process, the 
evaluation office requested some clarifications from the panels when necessary. The tone and style in the 
reports were not harmonized in the editing process. All the reports follow the original texts written by the 
panels as far as it was possible. 
The original evaluation material of the RCs, provided for the panellists is attached at the end of the 
report. It is essential to notice that the exported lists of publications and other scientific activities depend 
how the data was stored in the TUHAT-RIS by the RCs. 
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2 Evaluation feedback 
2.1 Focus and quality of the RC’s research 
 Description of 
 the RC’s research focus 
 the quality of the RC’s research (incl. key research questions and results) 
 the scientific significance of the RC’s research in the research field(s) 
 Identification of the ways to strengthen the focus and improve the quality of the RC’s research 
ASPECTS: Scientific quality, scientific significance, societal impact, innovativeness 
 
The RC Neuron is comprised of 12 research groups. Its strengths rely on an exceptional combination of 
organizational (see pt. 2.5), structural (pts. 2.2, 2.5), and scientific (pt. 2.1) elements. One important basis 
of Neuron is the Neuroscience Centre (NC), the founders of which have strategically assembled this centre 
and moved it to excellent international standing and scientific reputation. 
The overall mission of Neuron is “to carry out top-level basic research on development and functions 
of healthy and diseases nervous systems”. In order to achieve this goal, Neuron has generated a concept 
of a truly interdisciplinary nature, which facilitates hypothesis-driven approaches to nervous system 
diseases. Central to this concept are the mechanisms of synaptic interactions and plasticity, around which 
the founders of Neuron have skilfully placed a number of dedicated approaches focusing on inhibitory 
neurotransmission and the role of chloride homeostasis (Kaila), pathogenesis of epilepsies (Lehesjoki, 
Kaila), synaptic maturation (Lauri, Taira), neurotrophic factors (Castrén, Airaksinen), structural plasticity 
(Hotulainen), adhesion and matrix molecules in neuronal development and immune regulation (Rauvala), 
histaminergic transmitters in development and disease (Panula), computational analyses of synaptic 
network activity (Palva). The approaches are convincingly complementary, both in scientific and technical 
terms. 
The top level of Neuron shows in scientific quality that is outstanding by international standards, with 
respect to scientific output and input (see pt. 2.7). The science of Neuron is highly original and innovative. 
Scientific findings of Neuron have significantly contributed to setting the pace of the research field, and in 
parts have led to remarkable clinical translations. To mention just one of Neuron landmark findings, the 
group of Kaila has shown that respiratory alkalosis induced by hyperthermia can precipitate epileptic 
seizures, thereby introducing a novel pathophysiological principle to epileptogenesis and paving the way 
for novel therapeutic avenues. The overall output of Neuron is excellent, with an average of around 50 
publications/year, no publications in uncritical journals, few (<5%) in fair journals, the majority (>70%) in 
competitive and good journals, and a significant number (20–25%) in top-rank journals of Neuroscience 
and in interdisciplinary journals. This distribution indicates the strategy of Neuron for high quality output, 
and unequivocally testifies the success in striving for science at top-quality. 
The Neuron overall concept is successfully synergistic, as indicated by numerous common 
publications, the steady growth of research groups (7 in 2005 to 13 in 2010) and of competitive outside 
funding (see pt. 2.7). It is highly recommended that this strategy is strengthened. 
Numeric evaluation: 5 (Outstanding) 
2.2 Practises and quality of doctoral training 
 Organising of the doctoral training in the RC. Description of the RC’s principles for: 
 recruitment and selection of doctoral candidates 
 supervision of doctoral candidates 
 collaboration with faculties, departments/institutes, and potential graduate schools/doctoral 
programmes 
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 good practises and quality assurance in doctoral training 
 assuring of good career perspectives for the doctoral candidates/fresh doctorates 
 Identification of the RC’s strengths and challenges related to the practises and quality of doctoral 
training, and the actions planned for their development. 
 Additional material: TUHAT compilation of the RC’s other scientific activities/supervision of doctoral 
dissertations 
ASPECTS: Processes and good practices related to leadership and management 
 
The organization of a systematic neuroscience curriculum, initiated by Kai Kaila, makes a most valuable 
contribution to Neuron (and the Helsinki science community). Courses are ECTS certified, at levels ranging 
from minor subject studies to a Master’s Degree Program in Neuroscience. Doctoral students of Neuron 
can choose from three local doctoral programs (Finnish Grad School of Neuroscience; Helsinki Grad School 
of Biotech and Mol Biol, Helsinki Biomed Program). The tools for quality assurance include competitive 
open calls, ranking upon clear criteria, thesis committees, high quality teaching programs, and 
international exchange. Furthermore, Neuron researches have been actively setting up master’s level 
training in neuroscience (MNEURO) and biotechnology (HEBIOT), and participate to international 
networks of doctoral programs (EU Marie curie, EMBO, NENS). 
A total of 80 doctoral theses has been completed 2005–2010, which is a fair magnitude for an 
institution of the size of Neuron. The parallel lines of research and teaching represent a good example on 
how human resources/potential can be linked to scientific excellence, and there is no doubt that graduates 
will make their way in science. It would be interesting to obtain a more systematic follow-up survey of the 
graduates. 
For optimally exploiting human resources, for attracting the most creative minds, and for generating 
graduates in an increasing competition, Neuron and Helsinki University may consider investing into a 
dedicated MD/PhD program. The close connection of basic to medical research in Neuron may provide a 
feasible basis for this. 
Numeric evaluation: 5 (Outstanding) 
2.3 The societal impact of research and doctoral training 
 Description on how the RC interacts with and contributes to the society (collaboration with public, 
private and/or 3rd sector). 
 Identification of the ways to strengthen the societal impact of the RC’s research and doctoral training. 
 Additional material: TUHAT compilation of the RC’s other scientific activities. 
ASPECTS: Societal impact, national and international collaboration, innovativeness 
 
The most significant societal impact of Neuron resides in the strength of its research. Developmental 
disorders of the brain, neurodegenerative and psychiatric disorders impose a major burden to society and 
health care providers. Identification of underlying mechanisms by Neuron researchers thus is of highly 
significant societal impact. Further strengthening the impact is the increasing direct link of Neuron to 
medical science and to the development of novel treatment strategies (see pt. 2.1). The suggestion of 
Neuron to strengthen activities with pharmaceutical companies, making use for instance of the excellent 
Helsinki University campus infrastructure, and the participation of Neuron doctoral students in courses of 
biotechnology business skills, are thus appreciable activities, although not mandatory. Along the same 
line, the recent generation of Neuron spin-offs can be seen as convincing demonstration of Neuron’s 
attempts to commercialize research output. 
Providing insight of Neuron research to the public by a web-based computer game is a laudable first 
step, and Neuron might consider additional means to increase public recognition. Public days, pupils’ labs, 
public lectures by prominent speakers, simple lab courses including basic and clinical parts, have been 
proven highly attractive to the public. In view of the limited resources of Neuron, the Helsinki University 
might provide support in logistic and financial terms. 
Numeric evaluation: 4 (Excellent) 
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2.4 International and national (incl. intersectoral) research 
collaboration and researcher mobility 
 Description of  
 the RC’s research collaborations and joint doctoral training activities 
 how the RC has promoted researcher mobility 
 Identification of the RC’s strengths and challenges related to research collaboration and researcher 
mobility, and the actions planned for their development. 
ASPECTS: Scientific quality, national and international collaboration 
 
The excellent scientific reputation of Neuron is reflected by an exceptionally high proportion of staff 
members from foreign countries (40–50%), its contribution to several international research networks 
established after competitive evaluation (EU FP6 EPICURE, EU COST), memberships of numerous editorial 
boards of international scientific journals, and continued invitation for review articles in most prestigious 
international journals. The Neuroscience Graduate Program and Master’s program are parts of the CORTEX 
training network (EU Marie Curie), and the Network of European Neuroscience Schools (NENS), 
respectively. The international profile of Neuron also shows in the number of international collaborations, 
which exceed the national ones in number. 
A Scientific Advisory Board comprised of seven renowned international scientists, assures quality 
control to the highest international standards. Overall, the view of Neuron as being an international 
research and teaching organization is fully supported by the data. 
Given the limited human resources of the Finnish academic system, Neuron should consider foreign 
recruitment on a more systematic basis. The Neuron suggestion to develop personal contacts to far-east 
Universities is laudable, although a more systematic approach might be helpful here. Seeking the contact 
of foreign offices of granting agencies, Neuroscience or Biomedical societies, or other Neuroscience 
Centres might be a promising way. 
Numeric evaluation: 5 (Outstanding) 
2.5 Operational conditions 
 Description of the operational conditions in the RC’s research environment (e.g. research 
infrastructure, balance between research and teaching duties). 
 Identification of the RC’s strengths and challenges related to operational conditions, and the actions 
planned for their development. 
ASPECTS: Processes and good practices related to leadership and management 
 
The RC Neuron is characterized by i) an administrative organization independent of faculties, avoiding 
some of the constraints inherent to traditional faculties, ii) an assortment of newly generated groups, 
complementing the molecular/cellular expertise of Neuron by developmental neurobiology, zebrafish 
neurobiology, and medical genetics, iii) core facilities with functional microscopic imaging, cell culture, 
and phenotyping labs for both mice and zebrafish, providing the basis for being competitive in some of 
the most important models of nervous system function iv) a Master’s Program in Neuroscience and a 
Graduate School of Neuroscience, linking human resources and the scientific excellence of Neuron (see pt. 
2.4), v) a well-balanced organization and management structure, complemented by an external scientific 
advisory board assuring the highest quality control. 
These characteristics reflect an organizational, academic and structural profile that is truly outstanding 
in EU universities, and that may function as a prototype for integrating a highly effective research unit into 
a pre-existing university system. The founders of the Neuroscience Centre, Neuron and Helsinki University 
should be congratulated for their continued effort. 
Practically, one consequence is that a PI can devote most of the working time to research, and despite 
exceptionally low teaching duties (5–10%), the overall quality of teaching is very high (see pt. 2.3). 
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The strategic decision to extend the neuroscientific research areas and the respective recruitment of 
research groups have made a significant contribution to the overall scientific standing, and have also 
generated the need to develop infrastructures. Neuron has adequately reacted to the increasing 
infrastructural demand by establishing respective core units. Inclusion of optogenetic technologies will 
further increase the demand for molecular genetics, micro engineering and electrophysiological in vivo 
units. This infrastructural development has obviously been pursued with no respective increase of the 
intramural budget. In fact, a large fraction (60%) of the operational costs is said to be covered by 
extramural funds. While this is laudable, it also creates an increasingly problematic situation, given the 
need for further infrastructural implementation. A new animal facility with increased overall capacity (as 
indicated in the RC report) is certainly an adequate step to improve the situation. The Helsinki University is 
asked to consider additional and adequate means along the same line to support infrastructural 
development. 
The split location of Neuron at Viikki and Meilahti campuses seems to need some attention. While it 
seems to work well in practice, ways might be explored to even improve the conditions. 
2.6 Leadership and management in the researcher community 
 Description of  
 the execution and processes of leadership in the RC 
 how the management-related responsibilities and roles are distributed in the RC 
 how the leadership- and management-related processes support 
 high quality research 
 collaboration between principal investigators and other researchers in the RC 
 the RC’s research focus 
 strengthening of the RC’s know-how 
 Identification of the RC’s strengths and challenges related to leadership and management, and the 
actions planned for developing the processes 
ASPECTS: Processes and good practices related to leadership and management 
 
The organization of Neuron (the structures of academia, management and decision making, the quality 
assurance based on an external Scientific Advisory Board), convincingly fulfil the high quality standards of 
an independent research and teaching institute at a European university. Overall, the statement of the 
external Scientific Advisory Board that “this model could serve as a European-wide example of how to 
optimize the use of resources within an existing university system” is fully supported by available 
evidence. 
Every effort should be taken to continue and strengthen the RC Neuron and the underlying 
Neuroscience Centre, which can be seen as a landmark in the International Neuroscience Map, and as a 
highlight in the profile of the Helsinki University. 
2.7 External competitive funding of the RC 
• The RCs were asked to provide information of such external competitive funding, where: 
• the funding decisions have been made during 1.1.2005–31.12.2010, and  
• the administrator of the funding is/has been the University of Helsinki 
• On the e-form the RCs were asked to provide: 
1) The relevant funding source(s) from a given list (Academy of Finland/Research Council, 
TEKES/The Finnish Funding Agency for Technology and Innovation, EU, ERC, foundations, other 
national funding organisations, other international funding organizations), and 
2) The total sum of funding which the organisation in question had decided to allocate to the RCs 
members during 1.1.2005–31.12.2010. 
 Competitive funding reported in the text is also to be considered when evaluating this point. 
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ASPECTS: Scientific quality, scientific significance, societal impact, innovativeness and future significance 
 
Extra-mural funding amounts to a total of appr. 15.5 Mill € (appr 2.6 Mill € p.a.). For such a young 
institution, with only recent recruitment of major groups and young group leaders, this is a very good 
record, even more so as funding is a result of competitive project evaluation. 
2.8 The RC’s strategic action plan for 2011–2013 
• RC’s description of their future perspectives in relation to research and doctoral training. 
ASPECTS: Scientific quality, scientific significance, societal Impact, processes and good practices related to 
leadership and management, national and international collaboration, innovativeness, future significance 
 
The innovative nature and the excellence of Neuron in scientific, academic, administrational and structural 
terms have been outlined in detail above (pts. 2.1, 2.3, 2.5, 2.6). There is no need for major strategic 
changes or developments: the single most import actions will be the continuation of the Neuroscience 
Centre, and further development of the infrastructure. 
Neuron should be encouraged to exploit its perspectives along the experimental and clinical lines. 
Given the pre-existing excellence, and continued and extended support of the Helsinki University, the 
continued success of Neuron in scientific and academic terms is foreseeable. 
2.9 Evaluation of the category of the RC in the context of entity of 
the evaluation material (1-8) 
The RC’s fitness to the chosen participation category. 
Category 1. The research of the participating community represents the international cutting edge in its field. 
 
There is no doubt that research of the Neuron community reflects the international status and peer-
recognition. Neuron has made an outstanding contribution to the field of neuroscience and overall 
represents the international cutting edge in this field. 
Numeric evaluation: 5 (Outstanding) 
2.10 Short description of how the RC members contributed the 
compilation of the stage 2 material 
The processes employed were fair and appropriate. 
2.11 How the UH’s focus areas are presented in the RC’s research 
Focus area 2: The basic structure of life 
 
For details, see pt. 2.6 above. Overall, the program of Neuron is central to the UH’s focus on “Basic 
Structure of Life”, creates a significant part of the biomedical profile of UH, and, more specifically, has led 
to international visibility of UH in the field of neuroscience. 
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2.12 RC-specific main recommendations 
There is no need for major strategic changes or developments: Neuron should be encouraged to pursue its 
excellent scientific and strategic concepts, and to further exploit its perspectives along the experimental 
and clinical lines. 
The Helsinki University is asked to provide best possible support in order for this truly excellent RC to 
function. 
2.13 RC-specific conclusions 
The RC Neuron, based on the Neuroscience Centre, is characterized by i) a top level of scientific quality 
that is outstanding by international standards, with respect to both scientific output and input, ii) a 
research focus on synaptic interactions and plasticity, bearing high societal impact, iii) a carefully selected 
assortment of research groups, which were strategically selected to complement the molecular/cellular 
expertise by developmental neurobiology, zebrafish neurobiology, and medical genetics, iv) core facilities 
with functional microscopic imaging, cell culture, and phenotyping labs for both mice and zebrafish, 
providing the basis for being competitive in some of the most important models of nervous system 
function, v) a Master’s and Graduate Program in Neuroscience, supporting recruitment of best young 
researchers at an international scale and thereby linking human resources to the scientific excellence of 
Neuron, vi) a well-balanced organization and management structure, complemented by an external 
scientific advisory board, assuring the highest quality control, and vii) an administrative organization 
independent of faculties, avoiding some of the constraints inherent to traditional faculties. 
Together, this scientific and organizational concept may function as a prototype in the EU for 
integrating a highly effective research unit into a pre-existing university system. In fact, this concept has 
helped to form a research environment that is truly outstanding by international standards, with high peer 
recognition, which has made a significant contribution for making the Helsinki University visible as a top 
spot on the international neuroscience map. 
2.14 Preliminary findings in the Panel-specific feedback 
— 
2.15 Preliminary findings in the University-level evaluation 
Research Focus 
The RC Neuron is comprised of 12 research groups. Its strengths rely on an exceptional combination of 
organizational, structural, and scientific elements. These elements have been strategically assembled by 
the founders of Neuron, and their skilful exploitation and extension have developed Neuron into a 
neuroscience institution of excellent international standing and scientific reputation. A mere logical 
consequence is the certification of Neuron as a Finnish Centre of Excellence (Molecular Neurobiology until 
2006; Molecular and Integrative Neurobiology 2008–2011). 
The overall mission of Neuron is “to carry out top-level basic research on development and functions of 
healthy and diseases nervous systems”. In order to achieve this goal, Neuron has generated a concept of a 
truly interdisciplinary nature, which facilitates hypothesis-driven approaches to diseases of the nervous 
system. Central to this concept are the mechanisms of synaptic interactions and plasticity, around which 
the founders of Neuron have skilfully placed a number of dedicated approaches focusing on inhibitory 
neurotransmission and the role of chloride homeostasis (Kaila), pathogenesis of epilepsies (Lehesjoki, 
Kaila), synaptic maturation (Lauri, Taira), neurotrophic factors (Castrén, Airaksinen), structural plasticity 
(Hotulainen), adhesion and matrix molecules in neuronal development and immune regulation (Rauvala), 
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histaminergic transmitters in development and disease (Panula), computational analyses of synaptic 
network activity (Palva). The approaches are convincingly complementary, both in scientific and technical 
terms. 
The top level of Neuron shows in scientific quality that is outstanding by international standards, with 
respect to scientific output and input. The science of Neuron is highly original and innovative. Scientific 
findings of Neuron have significantly contributed to setting the pace of the research field, and in parts 
have led to remarkable clinical translations. To mention just one of Neuron landmark findings, the group of 
Kaila has shown that respiratory alkalosis induced by hyperthermia can precipitate epileptic seizures, 
thereby introducing a novel pathophysiological principle to epileptogenesis and paving the way for novel 
therapeutic avenues. The overall output of Neuron is excellent, with an average of around 50 
publications/year, no publications in uncritical journals, few (<5%) in fair journals, the majority (>70%) in 
competitive and good journals, and a significant number (20–25%) in top-rank journals of Neuroscience 
and in interdisciplinary journals. This distribution indicates the strategy of Neuron for high quality output, 
and unequivocally testifies of the success in striving for science at top-quality. 
The overall concept of Neuron is successfully synergistic, as indicated by numerous common 
publications, the steady growth of research groups (7 in 2005 to 13 in 2010) and of competitive outside 
funding. The strategic concept of Neuron has been extended towards in vivo/behaviourally oriented 
neuroscience and clinically oriented neuroscience, which is remarkable for two major reasons. First, the 
recruitment of the respective new groups and the establishment of the required technical infrastructure 
seem to have been pursued with no significant increase of the intramural budget. Second, the strategy is a 
wise one, as it bears the promise of strengthening mutual bounds between Neuron and the Helsinki 
biomedical and medical community in general, and of increasing public awareness of Neuron as a top rank 
neuroscience centre. It is highly recommended that this strategy is strengthened. 
 
Practices and Quality of Doctoral Training  
The organization of a systematic curriculum in neuroscience, initiated by Kai Kaila, makes a most valuable 
contribution to Neuron (and the Helsinki research community). Courses are ECTS certified, at levels 
ranging from minor subject studies to a Master’s Degree Program in Neuroscience. Doctoral students of 
Neuron can choose from three local doctoral programs (Finnish Grad School of Neuroscience; Helsinki 
Grad School of biotech and Mol Biol, Helsinki Biomed Program). The tools for quality assurance include 
competitive open calls, ranking upon clear criteria, thesis committees, high quality teaching programs, and 
international exchange. Furthermore, Neuron researches have been actively setting up master’s level 
training in neuroscience (MNEURO) and biotechnology (HEBIOT), and participate in international networks 
of doctoral programs (EU Marie Curie, EMBO, NENS). 
A total of 80 doctoral theses has been completed 2005–2010, which is a very fair output for an 
institution of the size of Neuron. The parallel lines of research and teaching represent a good example on 
how human resources/potential can be linked to scientific excellence, and there is no doubt that graduates 
will make their way in science. It would be interesting to obtain a more systematic follow-up survey of the 
graduates. 
For optimally exploiting human resources, for attracting the most creative minds, and for generating 
graduates in an increasing competition, Neuron and Helsinki University may consider investing into a 
dedicated MD/PhD program. The close connection of basic to medical research in Neuron may provide a 
feasible basis for this. 
 
Societal Impact 
The most significant societal impact of Neuron resides in the strength of its research. Developmental 
disorders of the brain, neurodegenerative and psychiatric disorders impose a major burden to society and 
health care providers. Identification of underlying mechanisms by Neuron researchers thus is of highly 
significant societal impact. Further strengthening the impact is the increasing direct link of Neuron to 
medical science and to the development of novel treatment strategies. The suggestion of Neuron to 
strengthen activities with pharmaceutical companies, making use, for instance, of the excellent Helsinki 
University campus infrastructure, and the participation of Neuron doctoral students in courses of 
biotechnology business skills, are thus appreciable activities, although not mandatory. Along the same 
22 
 
line, the recent generation of Neuron spin-offs can be seen as convincing demonstration of Neuron’s 
attempts to commercialize the research output. 
Providing insight of Neuron research to the public by a web-based computer game is a laudable first 
step, and Neuron might consider additional means to increase public recognition. Public days, pupils’ labs, 
public lectures by prominent speakers, simple lab courses including basic and clinical parts, have been 
proven highly attractive to the public. In view of the limited resources of Neuron, the Helsinki University 
and/or the City of Helsinki might provide support in logistic and financial terms. 
 
International and National Collaboration 
The excellent scientific reputation of Neuron is reflected by an exceptionally high proportion of staff 
members from foreign countries (40–50%), its contribution to several international research networks 
established after competitive evaluation (EU FP6 EPICURE, EU COST), memberships of numerous editorial 
boards of international scientific journals, and continued invitation for review articles in most prestigious 
international journals. The Neuroscience Graduate Program and Master’s program are parts of the CORTEX 
training network (EU Marie Curie), and the Network of European Neuroscience Schools (NENS), 
respectively. The international profile of Neuron also shows in the number of international collaborations, 
which exceed the national ones in number. 
The Scientific Advisory Board comprised of seven renowned international scientists, assures quality 
control to the highest international standards. Overall, the view of Neuron as being an international 
research and teaching organization is fully supported by the data. 
Given the limited human resources of the Finnish academic system, Neuron should consider foreign 
recruitment on a more systematic basis. The suggestion of Neuron to develop personal contacts to far-
east universities is laudable, although a more systematic approach might be helpful here. Seeking the 
contact of foreign offices of granting agencies, Neuroscience or Biomedical societies, or other 
Neuroscience Centres might be a promising way. 
 
Leadership and Management 
The organization of Neuron (the structures of academia, management and decision making, quality 
assurance based on an external scientific advisory board) convincingly fulfil the high quality standards of 
an independent research and teaching institute at a European university. Overall, the statement of the 
external Scientific Advisory Board that “this model could serve as a European-wide example of how to 
optimize the use of resources within an existing university system” is fully supported by available 
evidence. 
From the point of view of external reviewers it is difficult to understand that no decision has been 
reached yet if and how to continue Neuron into the third 5-year term (starting 2011?). Every effort should 
be taken to continue and strengthen the NC, which has been grown to a landmark in the International 
Neuroscience Map, and clearly is a highlight in the profile of the Helsinki University. 
 
External Funding 
Extra-mural funding amounts to a total of appr. 15.5 Mill € (appr 2.6 Mill € p.a.). For such a young 
institution, with only recent recruitments of major groups and young group leaders, this is a very good 
track record, even more so as funding is a result of competitive project evaluation. 
 
Strategic Action Plan 
The innovative nature and the excellence of Neuron in scientific, academic, administrational and structural 
terms have been outlined in detail above. There is no need for major strategic changes or developments: 
the single most import actions will be continuation of the NC. 
Neuron should be encouraged to exploit its perspectives along the experimental and clinical lines. 
Given the pre-existing excellence, and continued and extended support by the Helsinki University, the 
continued success of Neuron in scientific and academic terms is foreseeable. 
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Conclusions and Recommendations 
The RC Neuron is characterized by i) a top level of scientific quality that is outstanding by international 
standards, with respect to both scientific output and input; ii) a research focus on synaptic interactions 
and plasticity bearing high societal impact; iii) a carefully selected assortment of research groups, which 
were strategically selected to complement the molecular/cellular expertise in developmental 
neurobiology, zebrafish neurobiology, and medical genetics; iv) core facilities with functional microscopic 
imaging, cell culture, and phenotyping labs for both mice and zebrafish, providing the basis for being 
competitive in some of the most important models of the function of the nervous system; v) a Master’s and 
Graduate Program in Neuroscience, linking human resources to the scientific excellence of Neuron; vi) a 
well-balanced organization and management structure, complemented by an external scientific advisory 
board, assuring the highest quality control; and vii) an administrative organization independent of 
faculties, avoiding some of the constraints inherent to traditional faculties. 
Together, this scientific and organizational concept may function as a prototype in the EU for 
integrating a highly effective research unit into a pre-existing university system. In fact, this concept has 
formed a research environment that is truly outstanding by international standards, with high peer 
recognition, and has made a significant contribution for making Helsinki University visible as a top spot on 
the international neuroscience map. 
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3 Appendices 
A. Original evaluation material 
a. Registration material – Stage 1 
b. Answers to evaluation questions – Stage 2 
c. List of publications 
d. List of other scientific activities 
B. Bibliometric analyses 
a. Analysis provided by CWTS/University of Leiden 
b. Analysis provided by Helsinki University Library (66 RCs) 
 
 
 
 
 
International evaluation of research and doctoral training 
at the University of Helsinki 2005-2010 
 
         RC-SPECIFIC MATERIAL FOR THE PEER REVIEW 
 
 
 
 
NAME OF THE RESEARCHER COMMUNITY:  
Neuroscience Center (Neuron) 
 
LEADER OF THE RESEARCHER COMMUNITY:  
Professor Heikki Rauvala, Neuroscience Center 
 
 
RC-SPECIFIC MATERIAL FOR THE PEER REVIEW: 
 Material submitted by the RC at stages 1 and 2 of the evaluation 
- STAGE 1 material: RC’s registration form (incl. list of RC participants in an excel table) 
- STAGE 2 material: RC’s answers to evaluation questions 
 TUHAT compilations of the RC members’ publications 1.1.2005-31.12.2010 
 TUHAT compilations of the RC members’ other scientific activities 1.1.2005-31.12.2010 
 Web of Science(WoS)-based bibliometrics of the RC’s publications data 1.1.2005-31.12.2010 
(analysis carried out by CWTS, Leiden University) 
NB! Since Web of Science(WoS)-based bibliometrics does not provide representative results for most RCs representing 
humanities, social sciences and computer sciences, the publications of these RCs will be analyzed by the UH Library 
(results available by the end of June, 2011) 
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RC-SPECIFIC STAGE 1 MATERIAL (registration form) 
 
 
 
 
Name: Rauvala, Heikki 
E-mail:  
Phone: +358919157621 
Affiliation: Neuroscience Center 
Street address: Viikinkaari 4 
 
 
Name of the participating RC (max. 30 characters): Neuroscience Center (NC) 
Acronym for the participating RC (max. 10 characters): Neuron 
Description of the operational basis in 2005-2010 (eg. research collaboration, joint doctoral training 
activities) on which the RC was formed (MAX. 2200 characters with spaces): Research groups of the NC 
are selected based on the evaluation by the SAB (scientific advisory board) of the Center. In addition to the 
scientific quality of the applicants, complementarity of their expertises is taken into account in the 
evaluation and final selection of the groups to form a team of collaborating groups. As can be seen from 
the annual reports from the years 2005-2009 reporting the yearly publication lists of the NC, this policy has 
resulted in numerous collaborative publications of the groups.  
 
The evaluation has been discussed in the PI meeting of the NC. All PIs of the Center have expressed their 
wish to form an RC consisting of the NC groups. 
 
 
Main scientific field of the RC’s research: medicine, biomedicine and healt sciences 
RC's scientific subfield 1: Neurosciences 
RC's scientific subfield 2: --Select-- 
RC's scientific subfield 3: --Select-- 
RC's scientific subfield 4: --Select-- 
Other, if not in the list:  
 
 
Participation category: 1. Research of the participating community represents the international cutting 
edge in its field 
1 RESPONSIBLE PERSON 
2 DESCRIPTION OF THE PARTICIPATING RESEARCHER COMMUNITY (RC) 
3 SCIENTIFIC FIELDS OF THE RC 
4 RC'S PARTICIPATION CATEGORY 
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Justification for the selected participation category (MAX. 2200 characters with spaces):  The mission of 
the RC is to carry out top-level basic research on development and functions of the nervous system and on 
basic mechanisms of nervous system diseases. This is expected to lead to high publication activity in top-
tier scientific journals  and in high numbers of citations, which can be documented  for example in the ISI 
database.  It is therefore appropriate that the RC should be evaluated in the category 1, where the 
international cutting edge research is evaluated. 
 
 
Public description of the RC's research and doctoral training (MAX. 2200 characters with spaces): The 
Neuroscience Center was established as an independent research and teaching institute at the University of 
Helsinki in 2003. The mission is to carry out top-level basic research on development and functions of 
healthy and diseased nervous systems with the aim of being among the leading neuroscience institutes in 
Europe. 
 
Both research and teaching within the NC focus on four, partially overlapping areas (molecular and cellular 
neuroscience, developmental neuroscience, cognitive and systems neuroscience, and basic research of the 
nervous system diseases), the combination of which is necessary to understand the complicated processes 
within the nervous system. The NC currently houses 13 research groups led by independent principal 
investigators. It bridges neuroscience research activities between the biosciences campus in Viikki and the 
medical campus in Meilahti with two of the groups working in Biomedicum Helsinki. The NC has 
responsibility for three core facilities providing sophisticated technologies for groups within and outside the 
NC: the neuronal cell culture unit, the mouse behavioral unit and the zebrafish unit. The research groups 
are well networked within the NC, as well as both nationally and internationally. The research results are 
published in as high quality journals as possible with on average 40 publications per year, of which 8 
publications on average have been in scientific series with impact factory 8. 
 
The NC is active in postgraduate training with 20 doctoral theses completed from the center between 2005 
and 2010. Several doctorate students have positions in one of the three graduate schools closely linked to 
the NC: the national Finnish Graduate School of Neuroscience and the Graduate Schools in Biomedicine and 
in Biotechnology and Molecular Biology of the University of Helsinki. The NC provides a wide range of 
research-based teaching that covers of research areas within the NC and that integrates recent research 
with undergraduate and graduate courses. The NC has a central role in organizing the teaching curriculum 
of The Master’s Degree Program in Neuroscience, launched recently in cooperation with the Faculty of 
Biosciences. 
Significance of the RC's research and doctoral training for the University of Helsinki (MAX. 2200 
characters with spaces): Neuroscience is globally accepted as a key multidisciplinary field with a central 
position not only in biomedicine but also in psychology, the humanities and technology. It seems therefore 
obvious that the University of Helsinki as a leading European multi-disciplinary university must have an 
institution  devoted to neuroscience.  In the latest Public Service Review (European Union: issue 20, pp. 
396-397), the NC represents neuroscience research in Finland.  
5 DESCRIPTION OF THE RC'S RESEARCH AND DOCTORAL TRAINING 
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In addition to obvious academic reasons, neuroscience has a strong societal impact. This is due to the 
enormous burden of brain disorders to the societies.  Novel innovative strategies to diagnosis and 
treatment of neurodegenerative and psychiatric disorders are therefore urgently needed in the current 
society.  Basic research of normal and diseased nervous system is the key to resolve this problem. Until 
now, the NC research has created 3 spin-off companies working with potential solutions to diagnostics and 
treatment of brain disorders. As another example of societal interactions, the NC research has created part 
of the exhibition “Maailmaa mullistava tiede-Science Changing the World” that is being displayed in the 
Finnish Science Center Heureka and will be presented in 2011-2013 in science centers in Hague, Paris and 
Lisbon. 
 
The NC groups participate actively in the teaching programs of three graduate schools: Finnish Graduate 
School of Neuroscience (FGSN), Helsinki Graduate School in Biotechnology and Molecular Biology (GSBM) 
and Helsinki Biomedical Graduate School (HBGS). FGSN is a national graduate school chaired by the NC 
research director Kai Kaila.  GSBM is an inter-campus graduate school operating in Viikki and Meilahti that 
was founded and chaired several years by the NC director Heikki Rauvala (currently a board member). 
HBGS is a medically oriented graduate school operating on the Meilahti campus. 
Keywords: basic neuroscience research; brain diseases; societal impact; graduate schools 
 
 
Justified estimate of the quality of the RC's research and doctoral training at national and international 
level during 2005-2010 (MAX. 2200 characters with spaces): The NC has created an active and stimulating 
environment to study new questions in all major areas of neuroscience, from genetics and molecular 
interactions and single channels to network activities in human brain. This is reflected by the strong 
external funding of the research groups, highly cited publications in leading journals and the engagement of 
NC scientists  in several networks and positions of trust. Over 50% of all investigators are PhDs implicating a 
mature structure of the research staff. Interactive research within the NC has produced a number of 
breakthrough findings. These areas include novel roles of co-transporters, mechanisms of activity-
dependent and drug-induced plasticity, and synchrony in the frequency bands of human brain. Scientists 
within the NC are involved in two Centres of Excellence of the Academy of Finland and actively engaged in 
international networks, including EPICURE, EU COST, NORDFORSK. They are frequent evaluators of foreign 
research organizations, and serve in editorial boards of distinguished journals. 
 
Despite its relatively small size, the NC maintains three core facilities important for the whole university. 
The core facilities provide high-quality expert advice and services to the research community in mouse 
behavioral phenotyping, in novel imaging and behavioral methods of zebrafish, and in neuronal cell culture. 
The NC is strongly committed to high-quality research-based teaching within several areas of 
neurosciences.  
 
6 QUALITY OF RC'S RESEARCH AND DOCTORAL TRAINING 
 
 
4 
 
INTERNATIONAL EVALUATION OF RESEARCH AND DOCTORAL TRAINING AT THE 
UNIVERSITY OF HELSINKI  
 
RC-SPECIFIC STAGE 1 MATERIAL (registration form) 
 
 
The NC is committed to high-quality doctoral training organized mainly in the graduate schools. The 
curricula of the graduate schools, in which the NC is actively involved, provide a framework of the training, 
with several students having been successful in the competition for a salaried position. The high-quality 
research projects within the NC groups, however, are central in the training. All PhD students have an 
outside thesis follow-up group ensuring doctoral training of highest possible standards. Several young 
scientists have been recruited from the center to leading institutes around the world after completing their 
training within the NC. 
Comments on how the RC's scientific productivity and doctoral training should be evaluated (MAX. 2200 
characters with spaces): A thorough peer review, consisting of analysis of publication record, citations, 
invitations to major meetings and seminars, quality of research questions, originality of research, 
interactions within the center and international activities are all valid methods to analyze the NC. Although 
the NC is not primarily a teaching organization, its strong role in interdisciplinary teaching of all areas of 
neuroscience on doctoral (and also graduate) level should be considered. In addition to the number of 
doctoral degrees, the NC would like to see an evaluation of the current status of the former members. The 
value of the core facilities would be best evaluated by site visits and discussions with the younger group 
members. With respect to the cores facilities, it should be taken into account that they have been 
established and maintained from the basic funding of the NC, without special national core facility funding. 
They would greatly benefit from core funding, which would contribute to success of not only the NC but the 
whole university. In addition to purely scientific results, the activities should also be evaluated for 
commercial potential and societal impact. Several discoveries have led to new applications, commercial 
activities and cooperation with drug companies. The NC has been active now for 7 years, which is still 
rather short to evaluate the long-term effects of its foundation. However, at a time when the importance of 
maintaining functional ties between the campuses has become important, its role as an active bridge can 
also be evaluated. 
LIST OF RC MEMBERS
NAME OF THE RESEARCHER COMMUNITY: Neuron
RC-LEADER H. Rauvala
CATEGORY 1
Last name First name
PI-status 
(TUHAT, 
29.11.2010)
Title of research and 
teaching personnel Affiliation 
1 Airaksinen Matti x Group leader Neuroscience Center
2 Paatero Anja Post-doctoral fellow Neuroscience Center
3 Rossi Jari Post-doctoral fellow Neuroscience Center
4 Kupari Jussi Graduate student Neuroscience Center
5 Laakso Tiina Graduate student Neuroscience Center
6 Markkanen Marika Graduate student Neuroscience Center
7 Tornberg Janne Graduate student Neuroscience Center
8 Uvarov Pavel Graduate student Neuroscience Center
9 Castrén Eero x Research director Neuroscience Center
10 Anthoni Heidi Post-doctoral fellow Neuroscience Center
11 Dahlström-Heuser Vanina Post-doctoral fellow Neuroscience Center
12 Di Lieto Antonio Post-doctoral fellow Neuroscience Center
13 Karpova Nina Post-doctoral fellow Neuroscience Center
14 O'Leary Olivia Post-doctoral fellow Neuroscience Center
15 Rantamäki Tomi Post-doctoral fellow Neuroscience Center
16 Shmelev Anton Post-doctoral fellow Neuroscience Center
17 Tiraboschi Ettore Post-doctoral fellow Neuroscience Center
18 Wu Xuefei Post-doctoral fellow Neuroscience Center
19 Autio Henri Graduate student Neuroscience Center
20 Hokkanen Marie-Estelle Graduate student Neuroscience Center
21 Knuuttila Juha Graduate student Neuroscience Center
22 Lindholm Jesse Graduate student Neuroscience Center
23 Hotulainen Pirta x
Academy Research Fellow, 
project leader
Neuroscience Center
24 Bertling Enni Post-doctoral fellow Neuroscience Center
25 Koskinen Mikko Graduate student Neuroscience Center
26 Huttunen Henri x
Academy Research Fellow, 
project leader
Neuroscience Center
27 Sivanandam Thamil Post-doctoral fellow Neuroscience Center
28 Kaila Kai x Research director Department of Biosciences
29 Blaesse Peter Post-doctoral fellow Department of Biosciences
30 Ahmad Faraz Graduate student Department of Biosciences
31 Khirug Stanislav Graduate student Department of Biosciences
32 Sipilä Sampsa Post-doctoral fellow Department of Biosciences
33 Yamada Junko Post-doctoral fellow Department of Biosciences
34 Khirug Leonard x
Academy Research Fellow, 
group leader
Neuroscience Center
35 Kolikova Julia Post-doctoral fellow Neuroscience Center
36 Niittykoski Minna Post-doctoral fellow Neuroscience Center
37 Okuneva Olesey Post-doctoral fellow Neuroscience Center
38 Osmekhin Sergey Post-doctoral fellow Neuroscience Center
39 Pryazhnikov Evgeny Post-doctoral fellow Neuroscience Center
40 Shintyapina Aleksandra Post-doctoral fellow Neuroscience Center
41 Zobova Svetlana Post-doctoral fellow Neuroscience Center
42 Molotkov Dmitry Graduate student Neuroscience Center
43 Lauri Sari x
Academy Research Fellow, 
project leader
Neuroscience Center
44 Sallert Marko Graduate student Neuroscience Center
45 Vesikansa Aino Graduate student Neuroscience Center
46 Lehesjoki Anna-Elina x Research director Neuroscience Center
47 Kopra Outi Senior scientist Neuroscience Center
48 Anttonen Anna-Kaisa Post-doctoral fellow Neuroscience Center
49 Aula-Kahanpää Nina Post-doctoral fellow Neuroscience Center
50 Joensuu Tarja Post-doctoral fellow Neuroscience Center
51 Kettunen Kaisa Post-doctoral fellow Neuroscience Center
52 Lahtinen Ulla Post-doctoral fellow Neuroscience Center
53 Lehtinen Maria Post-doctoral fellow Neuroscience Center
54 Polvi Anne Post-doctoral fellow Neuroscience Center
55 Kousi Maria Graduate student Neuroscience Center
56 Kuronen Mervi Graduate student Neuroscience Center
57 Körber Inken Graduate student Neuroscience Center
58 Laari Anni Graduate student Neuroscience Center
59 Manninen Otto Graduate student Neuroscience Center
60 Siintola Eija Graduate student Neuroscience Center
61 Tegelberg Saara Graduate student Neuroscience Center
62 Palva Matias x
University researcher, project 
leader
Neuroscience Center
63 Palva Satu Post-doctoral fellow Neuroscience Center
64 Maila Tomi Graduate student Neuroscience Center
65 Monto Simo Graduate student Neuroscience Center
66 Rouhinen Santeri Graduate student Neuroscience Center
67 Panula Pertti x Research director Institute of Biomedicine
68 Chen Yu-Chia Post-doctoral fellow Institute of Biomedicine
69 Kudo Hisaaki Post-doctoral fellow Institute of Biomedicine
70 Semenova Svetlana Post-doctoral fellow Institute of Biomedicine
71 Priyadarshini Madhusmita Graduate student Institute of Biomedicine
72 Sallinen Ville Graduate student Institute of Biomedicine
73 Sundvik Maria Graduate student Institute of Biomedicine
74 Kolehmainen juha Post-doctoral fellow Institute of Biomedicine
75 Rauvala Heikki x Director Neuroscience Center
76 Kulesskaya Natalia Post-doctoral fellow Neuroscience Center
77 Paveliev Mikhail Post-doctoral fellow Neuroscience Center
78 Rouhiainen Ari Post-doctoral fellow Neuroscience Center
79 Tian Li Post-doctoral fellow Neuroscience Center
80 Tumova Sarka Post-doctoral fellow Neuroscience Center
81 Võikar Vootele
University researcher, project 
leader
Neuroscience Center
82 Hienola Anni Graduate student Neuroscience Center
83 Kiiltomäki Marjaana Graduate student Neuroscience Center
84 Kuja-Panula Juha Graduate student Neuroscience Center
85 Kulesskiy Evgeny Graduate student Neuroscience Center
86 Mankki Lauri Graduate student Neuroscience Center
87 Vanttola Päivi Graduate student Neuroscience Center
88 Zhao Xiang Graduate student Neuroscience Center
89 Taira Tomi x Group leader Neuroscience Center
90 Clarke Vernon Post-doctoral fellow Neuroscience Center
91 Molchanova Svetlana Post-doctoral fellow Neuroscience Center
92 Huupponen Johanna Graduate student Neuroscience Center
93 Juuri Juuso Graduate student Neuroscience Center
94 Segerstråle Mikael Graduate student Neuroscience Center
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Name of the RC’s responsible person: Rauvala, Heikki 
E-mail of the RC’s responsible person:   
Name and acronym of the participating RC: Neuroscience Center (NC), Neuron 
The RC’s research represents the following key focus area of UH: 2. Elämän perusrakenne – The basic 
structure of life 
Comments for selecting/not selecting the key focus area: The centre-of-excellence programs have been 
used as one criterion of key focus areas of research.  From  this viewpoint, the NC research belongs to the 
area of “The basic structure of life”.  The CoE “Programme of molecular neurobiology” (chaired by Heikki 
Rauvala) was functioning until 2006. The term of the renewed CoE “Finnish Centre of Excellence in 
Molecular and Integrative Neuroscience Research” (chaired by Mart Saarma) extends from the beginning of 
2008 until the end of 2013. Of the current NC groups, Rauvala, Castrén, Kaila, Airaksinen and Rivera (NC 
group leader from the beginning of 2011) belong to this CoE. Lehesjoki belongs to the CoE “Finnish Centre 
of Excellence in Complex Disease Genetics”. 
 
Although the CoEs to which NC PI´s belong, have been grouped to “The Basic Structure of Life”, the NC 
could be also grouped to “The thinking and learning human being” that includes brain research. 
Furthermore, part of the NC research belongs to systems neuroscience that has been associated in the 
evaluation to “The thinking and learning human being”. 
 
 
 Description of the RC’s research focus, the quality of the RC’s research (incl. key research 
questions and results) and the scientific significance of the RC’s research for the research 
field(s).  
The mission of the Neuroscience Center (NC) is to carry out top-level basic research on development 
and functions of healthy and diseased nervous systems. In particular, mechanistic explanations at the 
molecular/cellular level are searched for systems level phenomena, such as normal and pathological 
behaviour. To this end, research at the NC comprises four overlapping areas (molecular and cellular 
neuroscience, developmental neuroscience, cognitive and systems neuroscience, and basic research of 
the nervous system diseases), the combination of which is necessary to understand the complex 
processes within the nervous system.  
 The NC (http://www.helsinki.fi/neurosci/) was formally founded in 2002 and started its operation in 
2003. To ensure quality of research, the NC has had an international scientific advisory board (SAB) from 
its beginning. The SAB evaluates the applications for the group leader and research director positions 
that are based on international calls. The positions are filled for 5-year terms but can be renewed based 
on evaluation by the SAB.  
 Starting the NC from scratch has made it possible to build a team of complementary expertises. Synergy 
between the groups is reflected in numerous common publications (see the yearly publication lists 
2005-2010  starting in http://www.helsinki.fi/neurosci/research/Publications2005.pdf). During 2005-
2010, the NC has been growing steadily, mainly based on growth of competitive outside financing; the 
number of research groups was 7 in 2005 and 13 at the end of 2010. Of the research groups, Airaksinen, 
Castrén, Kaila, Lehesjoki, Rauvala and Taira have had financing from the centre-of-excellence programs 
BACKGROUND INFORMATION 
1 FOCUS AND QUALITY OF RC'S RESEARCH (MAX. 8800 CHARACTERS WITH SPACES) 
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of the Academy of Finland during 2005-2010 (see the annual reports in 
http://www.helsinki.fi/neurosci/NC/annual_reports.html ).  
 The number of publications where the NC is mentioned as a site of research has been about 50/year 
(range 40-55/year). Of the articles, 20-25 % have been published each year in top-tier journals (having 
the same or higher impact factor compared to J Neurosci); examples of this work are highlighted below 
as research of the highest significance for the research field. 
 From the methodological viewpoint, one bottleneck in the scientific community has been the lack of 
behavioural methods for phenotypic analysis of transgenic mice. To enhance multidisciplinary 
approaches to dissect normal and pathological nervous system functions, one of the first tasks of the NC 
was therefore to set up a mouse behavioural unit (see e.g. Võikar et al 2005 Genes Brain Behav 4: 240-
252; Zylka et al 2008 Neuron 60: 111-122).  
 Inhibitory neurotransmission from molecular/cellular to behavioural studies belongs to key subjects 
studied at the NC during 2005-2010. In particular, the key role of chloride homeostasis and the chloride 
transporters, such as KCC2, have been intensively investigated by the group of professor Kai Kaila and 
other groups of the NC (Blaesse et al 2006 J Neurosci 26: 10407-10419; Uvarov et al 2006 J Neurosci 26: 
13463-13473; Huberfield et al 2007 J Neurosci 27: 9866-9873; Li et al 2007 Neuron 56: 1019-1033; 
Uvarov et al 2007 J Biol Chem 28: 30570-30576; Khirug et al 2008 J Neurosci 28: 4635-4639; Sipilä et al 
2009 J Neurosci 29: 6982-6988; Uvarov et al 2009 J Biol Chem 284: 13696-13704; Khirug et al 2010 J 
Neurosci 30: 12028-12035; reviewed in Blaesse et al 2009 Neuron 61: 821-838).  
 Another major topic within the NC is the genetic background and pathogenesis of epilepsies and 
neurodegeneration accompanying epileptic syndromes. On this research line, the Lehesjoki group has 
established the genetic background of Marinesco-Sjögren syndrome (Anttonen et al 2005 Nat Genet 37: 
1309-1311), and implicated cystatin B in progressive myoclonus epilepsy, EPM1 (Lehtinen et al 2009 J 
Neurosci 29: 5910-5915). As regarding pathogenesis of seizures, the finding by the Kaila group that 
hyperthermia-induced respiratory alkalosis is able to precipitate seizures, is another interesting and 
clinically relevant finding (Schuchmann et al 2006 Nat Med 12: 817-823). 
 Novel mechanisms of synaptic plasticity and synaptic maturation have been revealed by the groups of 
Drs Sari Lauri and Tomi Taira. These groups have shown that kainate receptors are key components in 
the regulation of synaptic development, plasticity and network activity in brain (Lauri et al 2005 J. 
Neurosci 25: 4473-4484; Lauri et al 2006 Neuron 50: 415-429; Segerstrale et al 2010 J Neurosci 30: 
6507-6514; reviewed in Hanse et al 2009 Trends Neurosci 32: 532-537). 
 The roles of neurotrophic factors in neuronal plasticity, development  and drug actions is studied by the 
group of professor Eero Castrén and his collaborators. The Castrén group has shown a critical role for 
the neurotrophin BDNF (brain-derived neurotrophic factor) in learning, memory, emotionality and 
reactivation of developmental-like plasticity in the adult cerebral cortex (Sairanen et al 2005 J Neurosci 
25: 1089-1094; Maya Vetencourt et al 2008 Science 320: 385-388;  Sallert et al 2009 J Neurosci 29: 
11294-11303).  
 The Airaksinen group has shown the requirement of the GDNF (glial cell-derived neurotrophic factor) 
receptor 2 in epidermis innervation (Lindfors et al 2006 J Neurosci 26: 1953-1960). Another research 
line of the group deals with LRRTM (leucine-rich repeat transmembrane proteins) proteins in neuronal 
development, schizophrenia, and in cognitive and behavioural evolution (Francks et al 2007 Mol 
Psychiatry 12: 1129-1139; 12: 1057; Linhoff et al 2009 Neuron 61: 820-839).  
 The cytoskeletal side in the mechanisms of synaptic development and plasticity are mainly studied by 
Dr. Pirta Hotulainen and her collaborators. These studies have defined mechanisms of actin 
polymerization and depolymerization during dendritic spine morphogenesis (Hotulainen et al 2009 J Cell 
Biol 185: 323-339; Hotulainen and Hoogenraad 2010 J Cell Biol 189: 619-629). 
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 The group of professor Heikki Rauvala focuses on cell surface adhesion and extracellular matrix 
molecules in neuronal development, plasticity and disorders. The group has shown that the 
transmembrane heparan sulfate proteoglycan N-syndecan (syndecan-3) regulates laminar development 
of the cerebral cortex through its interactions with growth and differentiation factors (Hienola et al 2006 
J Cell Biol 174: 569-580). Roles of adhesion molecules in immune regulation and neuron/immune cell 
interactions form a major research line from the viewpoint of neuronal disorders (Rouhiainen et al 2007 
J Leuk Biol 81: 49-58; Tian et al 2007 J Cell Biol 178: 687-700; Tian et al 2008 Blood 111: 3615-3625; 
reviewed in Tian et al 2009 Trends Immunol 30: 91-99). 
 The group of professor Pertti Panula focuses on modulatory neurotransmitter systems and their roles in 
brain diseases. The group has shown that histaminergic neurons protect the developing hippocampus 
from kainic acid-induced neuronal damage (Kukko-Lukjanov et al 2006 J Neurosci 26: 1088-1097).  The 
group has set up the zebrafish facility and uses extensively the zebrafish model to study development 
and basic disease mechanisms (see e.g. Panula et al 2010 Neurobiol Dis 40: 46-57). 
 The group of Palva is instrumental for computational approaches required by the NC groups. The 
neuroinformatics approach, based on human MEG/EEG data, has been used to reveal neuronal 
synchrony underlying working memory networks and individual memory capacity (see e.g. Palva et al 
2005 J Neurosci 25: 5248-5258; Palva and Palva 2007 Trends Neurosci 30: 150-158; Monto et al 2008 J 
Neurosci 28: 8268-8272; Palva et al 2010 Proc Natl Acad Sci USA 107: 7580-7585). 
 Ways to strengthen the focus and improve the quality of the RC’s research. 
Active recruiting policy is instrumental to strengthen the focus and improve the quality of research. In 
2010, two group leader positions were declared open from the beginning of 2011. Of 32 applicants, Drs 
Claudio Rivera (previously working as a group leader in the Institute of Biotechnology) and Sari Lauri 
(previously working as an NC project leader) were selected based on recommendation by the SAB. The 
recruitments strengthen considerably the NC research  exploring mechanisms of synaptic plasticity and 
behaviour. 
 The NC research uses two animal models, the mouse and the zebrafish. Building of the new animal 
facility is a key issue for transgenic and behavioural studies of the NC.  Two-photon in vivo imaging 
studies on cortex and automated behavioural studies are connected to transgenic work, and are 
currently being developed. 
 The zebrafish unit focuses on the nervous system and already provides the possibility for accurate 
analysis of neuronal networks and for behavioural assessment. The zebrafish model is now being 
developed as a service for the whole bioscience community. 
 
 
  How is doctoral training organised in the RC? Description of the RC’s principles for recruitment and 
selection of doctoral candidates, supervision of doctoral candidates, collaboration with faculties, 
departments/institutes, and potential graduate schools/doctoral programmes, good practises and 
quality assurance in doctoral training, and assuring good career perspectives for the doctoral 
candidates/fresh doctorates.  
The NC has organized a systematic neuroscience curriculum that has been lacking in the University of 
Helsinki. Teaching at the NC has been organized according to the research areas covered by the Center, 
and includes both lecture series and hands-on courses. During 2005-2010, the regular teaching program 
(for current courses, see http://www.helsinki.fi/neurosci/education/courses.html)  has had the 
following parts: Molecular and cellular neuroscience (responsible person: Heikki Rauvala), 
Developmental neuroscience (responsible person: Eero Castrén), Functional neuroanatomy (responsible 
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persons: Matti Airaksinen and Pertti Panula), Synaptic signaling and plasticity (responsible persons: Tomi 
Taira and Sari Lauri), Systems neuroscience (responsible persons: Matias and Satu Palva) and Basic 
mechanisms of nervous system diseases (responsible person: Anna-Elina Lehesjoki). The courses 
organized by the NC are in English, and they are used for doctoral training through graduate schools. 
Currently, teaching provided by the NC equals the credits required for minor subject studies in 
neuroscience (25 ECTS credits), a doctoral degree (60 ECTS cr), or to complete a major in the 
international Master´s Degree Programme in Neuroscience (MNEURO, 120 ECTS cr).  
 The members of the NC are closely connected to graduate schools/doctoral programs that are 
operating in the University of Helsinki. The programs are funded by the Ministry of Education and the 
Academy of Finland. Nine NC group leaders belong to the Management Board of the Finnish Graduate 
School of Neuroscience (FGSN; founder and chairman , Kai Kaila). Helsinki Graduate School in 
Biotechnology and Molecular Biology (GSBM; currently Helsinki Graduate Program in Biotechnology and 
Molecular Biology, GPBM; founded and originally chaired by Heikki Rauvala who currently works in the 
Management Board) is another program recruiting doctoral students focusing on molecular/cellular 
neuroscience.  Helsinki Biomedical Graduate Program (HBGP) is the third relevant graduate school, and 
recruits PhD students working in biomedicine and neuroscience. Nearly all PhD students working in the 
research groups of the NC are registered in one of the three local doctoral programs. The NC follows the 
guidelines for good practices in doctoral training set by the doctoral programs and the faculties. Either 
the Medical Faculty or the Faculty of Biological Sciences awards the PhD degree to the successful 
doctoral candidate. 
 Tools for quality assurance in doctoral training include: (1) competitive open calls at the University´s 
web site and through relevant national and international email lists, (2) ranking of the applicants based 
on a short research plan and the CV, followed by interviews of the most successful applicants, (2) 
scientific quality of the group leader who is responsible for the day-to-day supervision of the doctoral 
student, (3) the practise of forming thesis committees, consisting of the supervisor and two outside 
members, that monitor the progress of the PhD work in yearly meetings until the thesis is ready for 
dissertation, (3) wide teaching programs of high quality (specific courses of novel techniques and 
courses of general skills required on many research areas, such as presentation skills, English scientific 
writing, entrepreneurship,  intellectual property rights, career planning, research ethics and handling of 
animals in experimental work),  and (4) international collaboration of the graduate programs.   
 National  networking within the bioscience community is an important tool for organized doctoral 
training in the graduate programs. During 2005-2010, FinBioNet (developed within the graduate school 
system by the GSBM chairman Heikki Rauvala and the GSBM coordinator Erkki Raulo) has become an 
established common activity of the Finnish graduate programs in biosciences.  FinBioNet informs 
practically every bioscience group within Finland about open positions, symposia , courses and  
financing possibilities,  and organizes common events of the graduate programs. The FinBioNet system 
includes 30 doctoral programs operating on the bioscience field in all universities of Finland. 
 In addition to systematic doctoral training, the members of the NC have been active in setting up basic 
master’s level training in neuroscience and biotechnology. The NC group leaders have had a crucial role 
in launching the International Master’s Program in Biotechnology (HEBIOT-program, Eero Castrén, 
chairman of the steering committee) that has been running since 2006. Furthermore, the teaching 
program of the NC has formed the basis of launching the international Master´s Degree Programme in 
Neuroscience- MNEURO (Tomi Taira, program leader; Kai Kaila and Eero Castrén as members of the 
steering committeee). MNEURO operates in collaboration with the Faculty of Biosciences and has been 
running since 2008. The master´s programs form one pathway to doctoral training in the graduate 
schools. 
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 All young and advanced researchers meet at a monthly seminars, where PhD students and postdocs 
present their results and progress, which are then discussed. Members of the NC actively participate in 
the biweekly Neuroscience Seminar Series, which is the major platform for visits by internationally 
renowned scientists. In addition, the RC members have organized several international scientific 
symposia (eg. Cellular Mechanisms of Cortical Functions, 2010; NGF 2010; The 4th International HMGB1 
Symposium: Signals of Tissue Damage Damage, 2010; Early development of brain functions: Basic, 
clinical and translational studies, 2009; Brain Development and Plasticity in Health and Disease, 2009; 
Brain & Pain, 2008; Developing Brain - Emerging Mind; 2007; Cortex Inaugural Symposium, 2006) that 
have been important training events for PhD students and senior researchers. 
 RC’s strengths and challenges related to the practises and quality of doctoral training, and the actions 
planned for their development. 
The RC’s research environment is highly international  and inspiring (see section 4) for young 
researchers. The wide national and international networks of the doctoral programs (eg. EU Marie Curie 
,Tempus and EMBO networks) as well as the extensive collaboration with research groups and 
biotechnology companies worldwide provide the students an excellent foundation for career 
perspectives. Furthermore, the well-organized practises in doctoral training form a strength of the RC. 
 The fact that the recruiting base in the Finnish bioscience community is quite small, forms a challenge. 
Therefore, operations to enhance systematic international recruitment are being pushed forward (see 
section 4). 
 The PhD´s have been so far mainly employed by the academia, which is becoming a bottleneck  in 
career development. Education to enhance working possibilities in companies (Doctors to companies, 
www.biobusiness.fi ) has been  therefore started. Connections to biobusiness are also provided through 
the Helsinki Business and Science Park. 
 
 
 Description of how the RC interacts with and contributes to the society (collaboration with public, 
private and/or 3rd sector).  
Networking with faculties of the University of Helsinki and of other Finnish universities is a characteristic 
feature of the NC both in research and in doctoral training (see section 2 and Appendix 1). In addition to 
the universities, the NC research is linked to relevant research in organizations outside of the university 
system. The cooperation agreement with Folkhälsan (Appendix 1) is the most prominent example of 
these activities; the position and salary of professor Lehesjoki is from the NC but her laboratory and 
basic research facilities are in the space of Folkhälsan in Biomedicum.  
 The NC aims at enhancing commercialization of research results. The doctoral students are encouraged 
to participate in an intensive training course on biotechnology business skills. This course gives the 
students an extensive overview of the business environment and the prerequisites for productive 
business operations. Moreover, neuroscience research frequently contributes to both basic research 
and applied innovation, and academic entrepreneurship is encouraged in the NC. 
 During 2005-2007, the NC had a commercialization program in collaboration with the Institute of 
Biotechnology (coordinated by Castrén at the NC) that has been financed by the Finnish Funding Agency 
for Technology and Innovation (TEKES). As a result of this activity, Hermo Pharma Ltd. has been founded 
in 2008 by Castrén, Huttunen, Rauvala and Saarma. The most advanced  project within Hermo Pharma 
Ltd. is based on reactivation of plasticity in adult brain (Castrén, see section 1), which is now entering 
into phase II clinical trials in an attempt  to treat amblyopia (“lazy eye”). Other drug development 
projects of Hermo Pharma Ltd. include use of neurotrophic factors in neurodegenerative conditions 
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(Saarma) and inhibition of HMGB1/RAGE signalling in inflammatory disorders (Rauvala). In addition to 
Hermo Pharma Ltd., two other spin-off companies have been so far created that are closely associated 
to the NC research. Neuroware Group Ltd. develops informatics tools, and is based on the research of 
the neuroinformatics group (Palva). Neurotar Ltd. is a CRO company offering imaging services to 
academia and industry (based on the work by the Khiroug group). 
 The NC groups are encouraged to present current scientific views to general audiences. Presentations in 
TV, radio and newspapers belong to this line of societal interactions. In addition, the NC researchers 
participate in organizing the Brain Awareness Week events (e.g. in 2007 a 7-day science fair directed for 
laymen in Sanomatalo, Helsinki). 
 A high-visibility window into research carried out in the NC and the University of Helsinki is provided by 
web-service based computer game, Cognitive Capacity Assessment (CCA), constructed by the 
neuroinformatics group (Palva, see section 1). The game can be used for testing and training of cognitive 
capacity in clinical setting, and in addition as a brain-fitness game. The game is on display in a very 
visible manner at the “Science Changing the World” exhibition that opened in the Finnish Science Center 
Heureka in 2010. The exhibition will be presented in three other science centers  (Hague, Paris and 
Lisbon),  and it is estimated to have a total of 1 million visitors. 
 Ways to strengthen the societal impact of the RC’s research and doctoral training. 
The strength of the NC is in molecular/cellular mechanisms underlying brain development/plasticity and 
nervous system disorders. This provides an excellent basis to find novel drug leads. This line of activities 
need to be further strengthened. Therefore, common activities need to be developed  with the Finnish 
company Orion Pharma. Furthermore, one challenge is to find common operations and shared financing 
with big pharma on the excellent campuses of Viikki and Meilahti (Biomedicum). To this end, the NC will 
organize a common meeting with Sanofi-Avensis (coordinated by Heikki Rauvala; Viikki, June 2011) to 
find research areas of common interest. 
 The RC´s of the University should encourage the PI´s to connect excellent science and societal 
interactions, e.g. when giving yearly awards (a current praxis in the University). At the end of 2010, the 
NC award for excellent performance was given to Docent Matias Palva for his innovative way of 
connecting excellent science and presenting it to general audiences (see “Science Changing the World” 
above). 
 
 
 
 Description of the RC’s research collaborations and joint doctoral training activities and how the RC 
has promoted researcher mobility.  
The proportion of foreign researchers within the NC is exceptionally high; during the last few years, 
scientists of non-Finnish origin have constituted 40-50 % of the NC researchers.  All NC groups 
collaborate with researchers based outside of Finland. Examples of articles published in 2005-2010 
together with international collaborators are listed in Appendix 2. 
 The NC Scientific Advisory Board consists of 7 renowned scientists, of which one is of Finnish origin  and 
all other are foreigners, which enhances international collaboration. The daily communication in the 
research groups and in teaching occurs largely in English, and all information to the personnel is 
transmitted in English. These features in the NC structure and practises enhance accommodation of 
foreigners in the environment of the NC. 
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 Besides long-standing and productive personal collaborative contacts of the NC group leaders with 
leading international groups, the NC as a whole is involved in several national and international 
programs directly related to  research collaboration and researcher mobility.  
 The Finnish Centre for International Mobility (CIMO) sponsors yearly Winter Schools coordinated by 
two principal investigators of the NC, Prof. Panula and Dr. Khirug. The Schools bring to Finland up to 25 
highly educated and motivated young scientists from Russia and Ukraine every year.  
 The neuroscience graduate program FGSN chaired by the NC research director Kaila is part of the 
CORTEX Training Network (Cooperation in Research and Training for European Excellence in 
Neurosciences), that was funded by the  Marie Curie Mobility Actions of the EU during 2006-2009.   
 Since the beginning of 2010, Kaila has been the director and grant holder of an EACEA Tempus IV –
funded European and Russian educational cooperation project “Postgraduate Training Network in 
Biotechnology of Neurosciences, BioN” to create Russian Graduate School for Neuroscience (RGSN). 
RGSN is the country’s first graduate school that provides teaching and training exclusively in English and 
utilizes educational principles established in the EU member states. 
 Through the doctoral program FGSN and the Center´s master´s program MNEURO, the NC is actively 
involved in the Network of European Neuroscience Schools (NENS). Participation in the NENS activities 
has been important to create educational principles and  practises in neuroscience education. 
 The Neuroscience Seminar series has been coordinated by the NC group leader Khirug and it attracts 
10-30 renowned speakers yearly. Its flexible scheme helps strengthen student training and promotes 
intersectoral collaboration. Our list of speakers  includes celebrated key opinion leaders from Max Plank 
Institutes (Germany), Stanford University, Duke University and National Institute of Health NIH (USA), 
University College London and University of Manchester (UK), CNRS and INSERM Institutes (France), 
RIKEN Brain Research Institute (Japan), Russian Academy of Science (Russia) and Karolinska Institutet 
(Sweden). 
 At the national level, the NC has extensively collaboration with faculties of the Finnish universities, with 
research organizations outside of the universities and with pharmaceutical industry (see section 3 and 
Appendix 1). 
 RC’s strengths and challenges related to research collaboration and researcher mobility, and the 
actions planned for their development. 
The NC is currently an international research and teaching organization, with about half of its 
researchers coming from abroad. The NC is actively involved in several well-organized international 
programs, which is one strength related to research collaboration and researcher mobility. 
 One challenge in foreign recruitment is local preselection of the competent candidates. The NC and the 
GPBM doctoral program are actively developing contacts for local preselection of competent 
candidates, such as the successful project in Wuhan, in which professor Deyin Guo, currently the Dean 
of the renowned College of Life Sciences in Wuhan, acts as the local advisor and contact person.   
 Collaboration with the Aalto University includes development of new optogenetic methods that are 
becoming highly interesting in neuroscience. Furthermore, the NC groups are currently actively 
developing novel ways to analyze axonal injury and recovery, allowing electrical and optical probing of 
single cells,  with the engineering expertise in micro and nanotechnology of the Aalto University. 
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 Description of the operational conditions in the RC’s research environment (e.g. research 
infrastructure, balance between research and teaching duties).  
From its inception, the NC has emphasised the need to develop research infrastructures that combine 
transgenic technologies in model organisms to behavioural phenotyping, imaging and 
electrophysiological analysis (see http://www.helsinki.fi/neurosci/research/index.html ). 
 The Mouse Transgenic Unit was started in 1996 and chaired  by Heikki Rauvala until 2008, when the 
Unit was transferred under the administration of the newly founded Animal Facility of the University of 
Helsinki. Currently, the NC PI Matti Airaksinen works as a Research Director of the Animal Facility who is 
responsible for the transgenic core facility functions on the Viikki and Meilahti campuses.  During its 
operation, the Transgenic Unit has produced hundreds of different mouse lines to research groups 
located within and outside of the University of Helsinki.   
 To exploit transgenic models in neuroscience, the Mouse Behavioural Unit was started in 1998 and 
chaired by Heikki Rauvala until 2010 when Dr Vootele Võikar was recruited to work as the NC PI who is 
responsibe for the behavioural core facility (see 
http://www.helsinki.fi/neurosci/research/Mouse_behavioral_unit.html ). The Behavioural Unit has set 
up a comprehensive test battery for behavioural phenotyping. More recently, installation of the newly 
developed system for home-cage automated mouse monitoring, IntelliCage, has extended the Unit´s 
abilities. 
 The Zebrafish Unit is chaired by the NC Research Director Pertti Panula (see  
http://www.helsinki.fi/neurosci/research/zebra_fish_unit.html ), and it produces services to many 
universities, research institutions and companies.  The current infrastructure includes translation 
inhibition with morpholino oligonucleotides, selection of new mutants from mutation screens, studies 
on mutants produced with targeted lesions in genomes, cloning of new genes and other basic molecular 
biology techniques, analysis of developing neuronal networks using high-resolution confocal and two-
photon imaging and automated quantitative behavioural analysis. 
 To improve quality and and consistency of primary neuron cultures, the NC has a centralized Neuronal 
Cell Culture Unit chaired by the NC Research Director Eero Castrén (see 
http://www.helsinki.fi/neurosci/research/neuronal_cell_culture_unit.html ). Most of the NC groups and 
many groups outside of the NC use the service for their research. 
 In addition to the core facilities discussed above, the Electrophysiology Units chaired by the NC 
Research Director Kai Kaila and the NC Group Leader Tomi Taira (e.g. setup for brain surgery, 3 setups 
for visually-guided  patch clamp, in vivo 32-channel electrophysiology system, two-photon laser 
scanning microscopy) belong to important infrastructures of the NC that are used by several groups. 
Furthermore, Neuronal Imaging (e.g. stereology workstation for quantitative analysis of tissue 
structures, confocal microscopy, TIRF and two-photon laser scanning microscopy) belongs to key 
operations at the NC that is required by many research groups, and is developed by the NC Group 
Leader Leonard Khirug. 
 The research infrastructures discussed above are used for both research and teaching. Teaching duties 
comprise about 5-10 % of the work load of the PIs, and the rest is mainly used for research. 
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 RC’s strengths and challenges related to operational conditions, and the actions planned for their 
development. 
The NC´s strength lies in the structure ensuring selection of top-level research groups (see section 1) and 
the modern infrastructure  having well-organized core functions.  
 The new animal facility to increase capacity in mouse mutant studies is a key issue to develop the 
infrastructure, and it is planned to be ready for use in 2012.  
 As regarding the informatics infrastructure, the Palva group is actively developing the NC 
Neuroinformatics Platform (based on OmniLyze). The platform allows management, analysis and 
efficient visualization of large experimental datasets, collaborative handling and analysis of the data by 
the group, and enables novel data mining approaches to be implemented.  
 About 60 % of the NC financing is based on competitive funding (for a proportion of the yearly outside 
competitive financing, see section 7; for a more detailed picture, see 
http://www.helsinki.fi/neurosci/NC/annual_reports.html ). Even the core functions depend partially on 
competitive funding. The groups will be encouraged to increase the activity in applying for competitive 
funding. 
 
 
 
 Description of the execution and processes of leadership in the RC, how the management-related 
responsibilities and roles are distributed in the RC and how the leadership- and management-related 
processes support high quality research, collaboration between principal investigators and other 
researchers in the RC, the RC’s research focus and strengthening of the RC’s know-how.  
The NC is an independent research and teaching institute of the University of Helsinki. The 
administrative structure is outlined in Appendix 1. 
 The NC is supervised and managed by the Board (http://www.helsinki.fi/neurosci/NC/board.html ) and 
the Director of the Center with the assistance of the Administrative Director. Professor Heikki Rauvala 
has acted as the Director and MSc Anna Mattila as the Administration Director from the inception of the 
NC. The connection of the NC to the faculty organization is arranged through the Board, in which the 
relevant faculties have their representatives (see Appendix 1).  
 Essential quality assurance systems are inherent in the structure of the NC. In particular, the 
international scientific advisory board (SAB; http://www.helsinki.fi/neurosci/NC/SAB.html ), composed 
of leading experts of the field, has played a key role to develop the NC. The SAB evaluates the 
applications, achievements of the research groups and initiatives to start new activities in research and 
teaching. Evaluations by the SAB, that are based on written material and interviews during the site visits, 
are the most important quality criteria for the decision-making by the Board and the Director. The site 
visits of the SAB enable thorough discussions of the Director with the SAB on the ongoing scientific work 
and the ways to improve technology and know-how of the NC. 
 The Director is responsible for the development of the Center and its scientific profile. To this end, the 
Director plans the target program that includes the scientific focus, the personnel plan and the budget. 
The Director makes the decision to take a research group to the NC. Furthermore, the Director oversees 
the preparation of matters for discussion by the Board and the execution of the decisions. It is expected 
that the Director participates in scientific activities of the Center. 
 The Board discusses the target program, its personnel plan and the budget, and accepts the annual 
report. Based on the report of the SAB, the Board makes a proposal to the Rector of the University to 
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appoint the Director. The Board gives a statement about the Director´s decision to take a research group 
to the Center. Furthermore, the Board decides of the strategic lines of teaching.  
 The Administration Director is responsible for administration and finances. The Administration Director 
is the head of the Administrative Services Unit and Maintenance personnel. 
 To foster collaboration between the researchers and to enhance multidisciplinary approaches in 
scientific work, complementarity of the research profiles is considered when selecting new groups to 
the NC. Furthermore, the  Neuroscience Seminar series and other common events are important to 
define areas of common interest. The Director organizes regularly PI meetings to discuss issues of 
common interest.  The PI meetings form an important basis for the Director for decision making, for 
example when buying new instruments or starting new technologies. 
 The practises followed in the Center have been collected in the NC guide. The NC guide is particularly 
important for foreigners since it contains the practical information found to be useful when starting the 
work within the NC and in the Finnish society. 
 RC’s strengths and challenges related to leadership and management, and the actions planned for 
developing the processes. 
The NC participated in 2005 as a start-up institute in the research assessment of the University of 
Helsinki. The panel chaired by Tim Hunt expresses the NC mode of operation and integration into the 
previously existing university system as a strength: ….” Given the interdisciplinary ramification of 
neuroscience, we believe that this model could serve as a European-wide example of how to optimize 
available resources within an existing university system. “ 
 The panel concludes: “From the viewpoint of the evaluating panel, we see every reason to continue 
such a successfully launched enterprise and recommend a permanent establishment of this promising 
institution. “ The biggest challenge in the NC management lies exactly here: the second 5-year term will 
be over at the end of 2010 but there is no decision how to continue, which makes credible leadership a 
challenging task. According to the central administration of the University, the result of the 2010 
evaluation will be considered before deciding how the neuroscience research is organized. 
 
 
 
 Listing of the RCs external competitive funding, where: 
- the funding decisions have been made during 1.1.2005-31.12.2010, and 
- the administrator of the funding is/has been the University of Helsinki 
 
 Academy of Finland (AF) - total amount of funding (in euros) AF has decided to allocate to the RC 
members during 1.1.2005-31.12.2010: 6310000 
 
 Finnish Funding Agency for Technology and Innovation (TEKES) - total amount of funding (in euros) 
TEKES has decided to allocate to the RC members during 1.1.2005-31.12.2010: 1280000 
 
 European Union (EU) - total amount of funding (in euros) EU has decided to allocate to the RC members 
during 1.1.2005-31.12.2010: 1390000 
 
 European Research Council (ERC) - total amount of funding (in euros) ERC has decided to allocate to the 
RC members during 1.1.2005-31.12.2010: 0 
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 International and national foundations – names of international and national foundations which have 
decided to allocate funding to the RC members during 1.1.2005-31.12.2010, and the amount of their 
funding (in euros).  
- names of the foundations: Sigrid Jusélius Foundation, Finnish Foundation for Alcohol Studies, 
Finska Läkaresällskapet, Magnus Ehrnrooth Foundation, Finnish Cancer Organisations, Sohlberg 
Foundation, Finnish Cultural Foundation, Emil Aaltonen Foundation, Letten Foundation, Jane and 
Aatos Erkko Foundation, Orion Farmos Research Foundation,  Finnish Parkinson Foundation, 
Instrumentarium Science Foundation, Medicinska Understödsföreningen Liv och Hälsa 
- total amount of funding (in euros) from the above-mentioned foundations: 4460000 
 
 Other international funding - names of other international funding organizations which have decided to 
allocate funding to the RC members during 1.1.2005-31.12.2010, and the amount of their funding (in 
euros). 
- names of the funding organizations: European Molecular Biology Organization, GlaxoSmithKline,  
Nordic Council of Ministers, NordForsk,  The Company of Biologists, Orion, Lundbeck, Alomone 
Labs 
- total amount of funding (in euros) from the above-mentioned funding organizations: 240000 
 
 Other national funding (incl. EVO funding and Ministry of Education and Culture funded doctoral 
programme positions) - names of other national funding organizations which have decided to allocate 
funding to the RC members during 1.1.2005-31.12.2010, and the amount of their funding (in euros). 
- names of the funding organizations: Biocentrum Helsinki, Biocenter Finland, Biomedicum Helsinki, 
EVO, NOVO, CIMO, University of Helsinki research grant, University of Helsinki (own assets), 
Orion Farmos, Federation of Finnish Learned Societies(TSV), Ministry of Education and Culture 
funded doctoral programme positions 
- total amount of funding (in euros) from the above-mentioned funding organizations: 1709000 
 
 
 
 Description of the RC’s future perspectives in respect to research and doctoral training. 
A few key issues in the NC´s future perspectives  have already been discussed above, such as active 
foreign recruitment policy and its future development (section 4),  and ongoing and future perspectives 
in cooperation with industry (section 3). Key areas of development in the general structure of the NC are 
shortly discussed below. 
 
1. Structure of the NC 
The NC has currently the personnel of  about 150 and 14 research groups, of which 12 work on the Viikki 
bioscience campus and 2 on the Meilahti medical campus (Biomedicum). The two-campus model 
enhances inter-campus cooperation of the University but has the disadvantage that neuroscience in the 
University is fragmented in many locations.  Bringing the high-quality research of both campuses in a 
common space, either in Meilahti or in Viikki, would greatly enhance contacts of researchers with 
different expertises, which is required in multidisciplinary projects. The NC could serve as the model of 
the administrative organization, commented in the University of Helsinki evaluation in 2005 as follows: 
“In terms of administrative organization, the Neuroscience center, which was created recently (in 
operation since 2002), is a skillfully constructed institution. “ The possibilities to unify the neuroscience 
research of the two campuses is currently being investigated with the University leadership. 
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2. Core facility functions of the NC 
Sophisticated technologies used in modern neuroscience require centralization as core facilities used by 
several groups inside and outside of the NC. 
 Mouse transgenic approaches belong to the key methods of the NC research groups. Building of the 
new and modern animal facility with the capacity of about 30 000 mice is the most important  operation 
for the transgenic units, and will facilitate use of modern technologies, such as conditional transgenic 
techniques. Planning of the research spaces of the new facility is currently chaired by Matti Airaksinen. 
 The NC has currently 3 two-photon microscopy setups, of which the latest version is currently being set 
up for in vivo imaging in cerebral cortex. Combined to transgenic techniques to label neurons, astrocytes 
or microglia, the method will be applied to visualize plasticity and regeneration of neuronal connections, 
for example after application of potential drugs. 
 In 2010, Dr. Vootele Võikar, who has been validating  novel automated behavioural methods in the 
University of Zurich and in the company NewBehavior, was recruited to the NC as a project leader.  The 
first steps in the use and further development in the home-cage mouse monitoring using IntelliCage 
have been now taken. This high-throughput approach to behavioral screening is expected to markedly 
increase the speed of experiments and optimally standardize housing conditions and experimental 
procedures with normal and genetically modified mice. 
 The NC has the exceptional situation in having two well-established animal models for its research. 
Mouse transgenics is currently offered as a service to all interested research groups, and the zebrafish 
facility, chaired by Panula,  is being developed on the same line. From the technological viewpoint, 
starting zinc finger technology to produce knockout fish will be a major development in the Unit. 
 The major development in the neuronal cell culture core facility, chaired by Castrén, includes increase 
in capacity to meet the growing demand. 
 The informatics infrastructure, developed and chaired by Palva, is now rapidly developing to be an 
essential core function within the NC. The NC Neuroinformatics Platform has been so far mainly used in 
the context of human brain imaging but is expected to find applications in general in work where large 
experimental datasets are handled, such as cellular imaging and automated behavioural monitoring (see 
also section 5). 
 
3. Doctoral training 
To lower the age at which the PhD degree is received, which is currently about 30 years, the volume of 
the thesis work should be lowered, without compromising the quality of papers included in the work. 
Active recruiting using the Marie Curie, Tempus and EMBO networks (section 2) or other organized 
networking, such as that with the Wuhan University in China (section 4), will be instrumental to further 
develop doctoral training. 
 
 
 
The topics of the evaluation have been thoroughly discussed in the PI meeting.  
Based on the discussion, the NC Director Heikki Rauvala has mainly written the report. Kai Kaila has 
provided material and part of the text for doctoral training (section 2). Leonard Khirug has provided the 
first draft for international and national research collaboration and researcher mobility (section 4). Tomi 
Taira has provided the first text for collaboration with the Aalto University (section 4). The 
administration has compiled the figures for funding (section 7). 
9 SHORT DESCRIPTION OF HOW THE RC MEMBERS HAVE CONTRIBUTED TO THE COMPILATION OF THE STAGE 2 
MATERIALS (MAX. 1100 CHARACTERS WITH SPACES). 
•
•
•
•
•
•
•
•
•
•
•
•
•
•
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Sairanen et al 2005 J Neurosci 25: 10891094  
Sunden-Cullberg et al 2005 Critical Care Med 33: 564-573  
Voikar et al 2005 Genes Brain Behav 4: 240-252  
Blaesse et al 2006 J Neurosci 26: 10407-10419  
De Witt et al 2006 J Neurosci 26: 1516-1530  
Lauri et al 2006 Neuron 50: 415-429  
Safiulina et al 2006 J Biol Chem 281: 23464-23470  
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Huberfeld et al 2007 J Neurosci 27: 9866-9873  
Lauren et al 2007 J Biol Chem 282: 5715-5725  
Li et al 2007 Neuron 56: 1019-1033  
Pangrši et al 2007 J Biol Chem282: 28749-28758  
Tanaka et al 2007 Neuron 54: 787-800  
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A2 Review in scientific journal 5 4 1 3 1 5 19 
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A4 Article in conference publication (refereed)    2  1 3 
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B3 Unrefereed article in conference proceedings    1 1 1 3 
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no. 18, pp. 4473-4484. 
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induced seizures', Neurobiology of Disease, vol 20, no. 1, pp. 155-169. 
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Lozada, A, Munyao, N, Sallmen, T, Lintunen, M, Leurs, R, Lindsberg, PJ, Panula, P 2005, 'Postischemic regulation of central histamine 
receptors', Neuroscience, vol 136, no. 1, pp. 371-379. 
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Raulo, E, Tumova, S, Pavlov, I, Pekkanen, M, Hienola, A, Klankki, E, Kalkkinen, N, Taira, T, Kilpeläinen, I, Rauvala, H  2005, 'The two 
thrombospondin type 1 repeat domains of the heparin-binding growth-associated molecule bind to heparin/heparan sulfate and regulate 
neurite extension and plasticity in hippocampal neurons', Journal of Biological Chemistry, vol 280, no. 50, pp. 41576-41583. 
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AG & Co. 
D1 Article in professional journal 
2008 
Shulga, A, Thomas-Crusells, J, Sigl, T, Blaesse, A, Mestres, P, Meyer, M, Yan, Q, Kaila, K, Saarma, M, Rivera Baeza, C, Giehl, K 2008, 
'Vaurioituneet hermosolut saavat kehityksenaikaisia ominaisuuksia',  Duodecim, vol 124, pp. 1766. 
2009 
Shulga, A, Blaesse, A, Kysenius, K, Huttunen, HJ, Tanhuanpää, K, Saarma, M, Rivera Baeza, C 2009, 'Tyroksiini edistää aivoperäisen 
neurotrofisen tekijän välityksellä vaurioituneiden hermosolujen selviytymistä', Duodecim, vol 125, no. 21. 
2010 
Lehesjoki, A, Gardiner, R 2010, 'Unverricht-Lundborg disease and ceroid lipufuscinoses', Epilepsia, vol 51, no. Suppl 5, pp. 76. 
Rantamäki, T 2010, 'Aivoyhdyshenkilö apteekkiin', Apteekkari : Suomen apteekkarilehti, vol 99, no. 7-8, pp. 31. 
E1 Popular article, newspaper article 
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2005 
Rantamäki, T 2005, 'Miksi masennuslääke kohottaa mielialaa?', OmaPlus. 
2009 
Lehesjoki, A, Kälviäinen, R 2009, 'Unverricht-Lundborgin etenevän myoklonusepilepsian (EPM1) tautimekanismit, Suomen Akatemian 
NEURO-projekti (2006-2009)', Epilepsia-lehti, vol 3, pp. 14-16. 
Lehesjoki, A 2009, 'Etenevän myoklonus-epilepsian (EPM1) tautimekanismit', Epilepsia-lehti, vol 41, no. 3, pp. 14-16. 
2010 
Rantamäki, T 2010, 'Änkytys lähtee aivoista, mutta miten', Puheenvuoro. 
H1 Patents 
2006 
Airaksinen, M, Lindahl, MS, Timmusk, T, Poteriaev, D, Rossi, J, Saarma, M 2006, Patentti: Compounds related to or derived from 
GFRƒÑ4 and their use, EP 1257581 . 
2007 
Saarma, M, Laurikainen, A, Hiltunen, J, Airaksinen, M, Klinge, E 2007, Neurotrophic factors in the treatment of peripheral nerve 
dysfunction of pelvic area, EP 1 181 042 B1. 
2010 
Rauvala, H, Rouhiainen, A, Huttunen, HJ 2010, Invention disclosure: Antibodies against acetylated HMGB1 and uses thereof,. 
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1 Analysis of activities 2005-2010 
 
- Associated person is one of Matti Airaksinen ,  Anja Onerva Paatero ,  Jari Rossi , Jussi 
Kupari ,  Tiina Laakso ,  Marika Markkanen ,  Janne Tornberg, Pavel Uvarov , 
 Eero Castrén ,  Vanina Dahlström-Heuser ,  Antonio Di Lieto , 
 Nina Karpova , Tomi Rantamäki ,  Anton Shmelev, Ettore Tiraboschi , 
 Xuefei Wu ,  Henri Autio ,  Marie-Estelle Hokkanen ,  Juha 
Knuuttila ,  Jesse Lindholm ,  Pirta Hotulainen ,  Enni Anita Bertling , 
 Mikko Koskinen ,  Henri Juhani Huttunen ,  Kai Kaila , Peter 
Blaesse ,  Faraz Ahmad ,  Stanislav Khirug , Sampsa Tapani Sipilä , 
Leonard Khirug , Yulia Kolikova , Minna Johanna Niittykoski , 
 Evgeny Pryazhnikov ,  Dmitry Molotkov ,  Sari Lauri ,  
Marko Sallert ,  Aino Vesikansa ,  Anna-Elina Lehesjoki ,  Outi Kopra , 
 Anna-Kaisa Anttonen ,  ,  Tarja Hannele Joensuu ,  , 
 ,  Kaisa Maria Kettunen ,  Ulla Lahtinen ,  Anne Polvi , 
Maria Kousi ,  Mervi Kuronen ,  Inken Körber , Otto Manninen , 
 Eija Annika Siintola ,  Saara Susanna Tegelberg ,  ,  Matias 
Palva ,  Satu Palva , Simo Monto ,  Santeri Rouhinen ,  Pertti 
Panula ,  Yu-Chia Chen ,  Hisaaki Kudo ,  Madhusmita Priyadarshini , 
 Ville Johannes Sallinen ,  Maria Sundvik ,  Heikki Rauvala , 
 Natalia Kulesskaya ,  Mikhail Paveliev ,  Ari Rouhiainen , 
Li Tian ,  Sarka Tumova, Vootele Voikar ,  Anni Hienola, Marjaana Kiiltomäki , 
 Juha Kuja-Panula , Evgeny Kulesskiy ,  Lauri Mankki , 
 Päivi Vanttola ,  Xiang Zhao ,  Tomi Taira ,  Vernon Clarke , 
 Svetlana Molchanova ,  Johanna Huupponen ,  Juuso Juuri , 
 Mikael Segerstråle ,  
 
Activity type Count 
Supervisor or co-supervisor of doctoral thesis 80 
Prizes and awards 14 
Editor of research journal 14 
Peer review of manuscripts 172 
Assessment of candidates for academic posts 30 
Membership or other role in review committee 16 
Membership or other role in research network 15 
Membership or other role in national/international committee, council, board 73 
Membership or other role in public Finnish or international organization 17 
Membership or other role of body in private company/organisation 8 
Participation in interview for written media 9 
Participation in radio programme 8 
Participation in TV programme 8 
Participation in interview for web based media 2 
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2 Listing of activities 2005-2010 
Supervisor or co-supervisor of doctoral thesis 
Eero Castrén ,  
Supervised Graduate Student: Eija Koponen, Eero Castrén, 2005, Finland 
Supervised Graduate Student: Jussi Väisänen, Eero Castrén, 2005, Finland 
Supervised Graduate Student: Tobias Gyarfas, Eero Castrén, 2005  2006, Germany 
Supervised graduate student: Tomi Rantamäki, Eero Castrén, 28.10.2006, Finland 
Supervisor of doctoral thesis: Jesse Lindholm, Eero Castrén, 2006  … 
Supervisor of doctoral thesis: Juha Knuuttila, Eero Castrén, 2006  …, Finland 
Supervisor of doctoral thesis: Marie-Estelle Hokkanen, Eero Castrén, 2006  …, Finland 
Supervised graduate student: Mikko Sairanen, Eero Castrén, 26.05.2007, Finland 
Supervised graduate student: Topi Tervonen, Eero Castrén, 02.02.2008, Finland 
Supervisor of doctoral thesis: Henri Autio, Eero Castrén, 2008  …, Finland 
Supervised graduate student: Rimante Minkeviciene, Eero Castrén, 17.12.2009, Finland 
Pirta Hotulainen ,  
Supervised graduate student: Mikko Koskinen, Pirta Hotulainen, 2010  … 
Kai Kaila ,  
PhD thesis / M. Palva, Kai Kaila, 03.2005, Finland 
PhD thesis supervision / I. Kirilkin, Kai Kaila, 2005  … 
PhD thesis supervision / S. Khirug, Kai Kaila, 2005  2010, Finland 
PhD thesis / S. Sipilä, Kai Kaila, 06.2006, Finland 
PhD thesis / Z. Horn, Kai Kaila, 10.2007  2010, Sweden 
PhD thesis supervision / A. Yukin, Kai Kaila, 2007  … 
PhD thesis / E. Ruusuvuori, Kai Kaila, 11.2008, Finland 
PhD thesis / H. Li, Kai Kaila, 02.2008, Finland 
PhD thesis supervision / F. Ahmad, Kai Kaila, 01.05.2008  2012, Finland 
PhD thesis supervision / A. Tokariev, Kai Kaila, 2009  … 
PhD thesis / T. Viitanen, Kai Kaila, 06.2010, Finland 
PhD thesis supervision / M. Helmy, Kai Kaila, 2010  2013, Finland 
Peter Blaesse ,  
PhD Thesis supervison, Peter Blaesse, 01.05.2008  …, Finland 
Leonard Khirug ,  
Co-supervision of PhD thesis by Ilya Kirilkin, Leonard Khirug, 01.01.2005  01.01.2012, Finland 
Co-supervision of PhD thesis by Alexey Yukin, Leonard Khirug, 01.01.2007  01.01.2012, Finland 
Co-supervision of PhD thesis of Dmytro Toptunov, Leonard Khirug, 01.12.2010  01.01.2015, Finland 
Supervision of PhD thesis by Dmitry Molotkov, Leonard Khirug, 01.01.2010  01.01.2014, Finland 
Supervision of PhD thesis by Mikhail Kislin, Leonard Khirug, 01.10.2010  01.01.2015, Finland 
Sari Lauri ,  
Supervisor of doctoral thesis: Aino Vesikansa, Sari Lauri, 2004  … 
Supervisor of doctoral thesis: Johanna Huupponen, Sari Lauri, 2006  … 
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Supervisor of doctoral thesis: Juuso Juuri, Sari Lauri, 2006  … 
Supervisor of doctoral thesis: Marko Sallert, Sari Lauri, 2006  … 
Supervisor of doctoral thesis: Natalia Luchkina, Sari Lauri, 2010  … 
Supervisor of doctoral thesis: Prasanna Sakha, Sari Lauri, 2010  … 
Anna-Elina Lehesjoki ,  
Supervision of doctoral thesis: Auli Siren, Anna-Elina Lehesjoki, 2004  25.04.2011, Finland 
Supervision of doctoral thesis: Saara Tegelberg, Anna-Elina Lehesjoki, 2004  2012, Finland 
Supervision of doctoral thesis: Mervi Kuronen, Anna-Elina Lehesjoki, 2005  2012, Finland 
Supervision of doctoral thesis: Hanna Västinsalo, Anna-Elina Lehesjoki, 2006  2011, Finland 
Supervision of doctoral thesis: Jukka Kallijärvi, Anna-Elina Lehesjoki, 2006, Finland 
Supervision of doctoral thesis: Kirsi Alakurtti, Anna-Elina Lehesjoki, 2006, Finland 
Supervision of doctoral thesis: Riikka Hämäläinen, Anna-Elina Lehesjoki, 2006, Finland 
Supervision of doctoral thesis: Maria Kousi, Anna-Elina Lehesjoki, 2007  2011, Finland 
Supervision of doctoral thesis: Otto Manninen, Anna-Elina Lehesjoki, 2007  2012, Finland 
Supervision of doctoral thesis: Anna-Kaisa Anttonen, Anna-Elina Lehesjoki, 2008, Finland 
Supervision of doctoral thesis: Eija Siintola, Anna-Elina Lehesjoki, 2008, Finland 
Supervision of doctoral thesis: Anni Laari, Anna-Elina Lehesjoki, 2009  …, Finland 
Supervision of doctoral thesis: Inken Körber, Anna-Elina Lehesjoki, 2009  …, Finland 
Supervision of doctoral thesis: Markus Lommi, Anna-Elina Lehesjoki, 2010  …, Finland 
Matias Palva ,  
Doctoral student supervisor: Simo Monto, Matias Palva, 2007  2010, Finland 
Doctoral student supervisor: Santeri Rouhinen, Matias Palva, 2010, Finland 
Doctoral student supervisor: Shrikanth Kulashekhar, Matias Palva, 2010, Finland 
Pertti Panula ,  
Supervisor of doctoral thesis: Maria Sundvik, Pertti Panula, 2005  …, Finland 
Thesis supervision: Adrian Flores Lozada, Pertti Panula, 02.09.2005, Finland 
Thesis supervision: CongYu Jin, Pertti Panula, 03.06.2005, Finland 
Thesis supervision: Kimmo Michelsen, Pertti Panula, 26.08.2005, Finland 
Thesis supervision: Minna-Liisa Änkö, Pertti Panula, 16.12.2005, Finland 
Supervisor of doctoral thesis: Madhusmita Priyadarshini, Pertti Panula, 2007  … 
Supervisor of doctoral thesis: Stanislav Rozov, Pertti Panula, 2007  … 
Supervisor of doctoral thesis: Raphaela Kaisler, Pertti Panula, 2008  2010 
Thesis supervision: Tiina-Kaisa Kukko-Lukjanov, Pertti Panula, 16.05.2008, Finland 
Thesis supervision: Ville Sallinen, Pertti Panula, 22.06.2009, Finland 
Supervisor of doctoral thesis: Jenni Vanhanen, Pertti Panula, 2010  … 
Heikki Rauvala ,  
Supervision of the graduate student: Ari Rouhiainen, Heikki Rauvala, 2003  2008 
Supervision of the graduate student: Kathleen Gransalke, Heikki Rauvala, 2003  2009 
Supervision of the graduate student: Vootele Võikar, Heikki Rauvala, 26.08.2006 
Supervision of the graduate student: Anni Hienola, Heikki Rauvala, 24.02.2007 
Supervision of the graduate student: Lauri Mankki, Heikki Rauvala, 2007  2010 
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Supervision of the graduate student: Evgeny Kulesskiy, Heikki Rauvala, 2010 
Supervision of the graduate student: Juha Kuja-Panula, Heikki Rauvala, 2010 
Supervision of the graduate student: Marjaana Kiiltomäki, Heikki Rauvala, 2010 
Supervision of the graduate student: Päivi Vanttola, Heikki Rauvala, 2010 
Supervision of the graduate student: Xiang Zhao, Heikki Rauvala, 2010 
Tomi Taira ,  
Supervisor of doctoral thesis: Aino Vesikansa, Tomi Taira, 2004  …, Finland 
Supervisor of doctoral thesis: Mikael Segerstråle, Tomi Taira, 2004  … 
Supervisor of doctoral thesis: Ivan Pavlov, Tomi Taira, 2005 
Supervisor of doctoral thesis: Johanna Huupponen, Tomi Taira, 2005  … 
Supervisor of doctoral thesis: Juuso Juuri, Tomi Taira, 2008  … 
Supervisor of doctoral thesis: Natalia Luchkina, Tomi Taira, 2009  … 
Prizes and awards 
Eero Castrén ,  
Sigrid Juselius professorship in Neuroscience, Eero Castrén, 2003  2012, Finland 
Suomalaisen tiedeakatemian jäsen, Eero Castrén, 19.04.2004  …, Finland 
Kai Kaila ,  
Academy Professor, Kai Kaila, 1996  2006, Finland 
Viikki Science Park Innovation Prize, Kai Kaila, 2006 
Ella and Georg Ehrnrooth Foundation Honorary Prize, Kai Kaila, 2010, Finland 
Sampsa Tapani Sipilä ,  
Novartis prize for the best Ph.D. thesis in Finland, Sampsa Tapani Sipilä, 2007 
Sari Lauri ,  
Best Thesis of the year-award , Dissertationes Biocentri viikki Universitasis Helsingiensis, Sari Lauri, 1999  … 
Thesis Prize, University of Helsinki, Sari Lauri, 1999  … 
L'oreal - Unesco For Women in Science - Award, Sari Lauri, 2010  … 
Anne Polvi ,  
Medix-palkinto astmageenin löytäjille, Anne Polvi, 21.10.2005 
Matias Palva ,  
Best PhD Thesis in Neuroscinece 2005, Matias Palva, 2005, Finland 
Outstanding PhD thesis 2005, Matias Palva, 2005, Finland 
Satu Palva ,  
Novartis-Exelon award of the Finnish Brain Research Society for the Best PhD Thesis in Neuroscience, 2007., Satu Palva, 2007  … 
Mikael Segerstråle ,  
Vuoden opettaja 2009, Mikael Segerstråle, 21.04.2010 
Editor of research journal 
Eero Castrén ,  
Editorial board member: Recent Patents on CNS Drug Discovery, Eero Castrén, 2005  … 
Editorial board member: Brain Structure and Function, Eero Castrén, 2006  2010 
Editorial board member: Cellular and Molecular Neurobiology, Eero Castrén, 2009  … 
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Anna-Elina Lehesjoki ,  
Annals of Medicine, Anna-Elina Lehesjoki, 01.01.2003  31.12.2006, Finland 
Anna-Kaisa Anttonen ,  
Epilepsy Research, Anna-Kaisa Anttonen, 01.01.2006  31.12.2006 
Pertti Panula ,  
Acta Histochemica, Pertti Panula, 01.01.2004  31.12.2010, Netherlands 
Journal of Neurochemistry, Pertti Panula, 01.01.2004  31.12.2010 
Cell and Tissue Research, Pertti Panula, 01.01.2005  31.12.2010, Germany 
Histochemistry and Cell Biology, Pertti Panula, 01.01.2005  31.12.2010, Germany 
Journal of Chemical Neuroanatomy, Pertti Panula, 01.01.2005  31.12.2010, Netherlands 
Acta Physiologica, Pertti Panula, 2009, Netherlands 
European journal of neuroscience, Pertti Panula, 2009 
Neuroscience, Pertti Panula, 2009 
Tomi Taira ,  
European Journal of Neuroscience, Tomi Taira, 2008  2009 
Peer review of manuscripts 
Matti Airaksinen ,  
J Neurochem Eur J Neurosci Neurobiol Disease, Matti Airaksinen, 01.01.2005  31.12.2005 
BMC Gastroenterol, Matti Airaksinen, 01.01.2006  31.12.2006 
Cell Tiss Res, Matti Airaksinen, 01.01.2006  31.12.2006 
J Biol Chem, Matti Airaksinen, 01.01.2006  31.12.2006 
J Cell Biol, Matti Airaksinen, 01.01.2006  31.12.2006 
J Mol Histol, Matti Airaksinen, 01.01.2006  31.12.2006 
J Neurochem, Matti Airaksinen, 01.01.2006  31.12.2006 
Mol Cell Neurosci, Matti Airaksinen, 01.01.2006  31.12.2006 
Neuroscience, Matti Airaksinen, 01.01.2006  31.12.2006 
Pain, Matti Airaksinen, 01.01.2006  31.12.2007 
International Journal of Developmental Neuroscience, Matti Airaksinen, 01.01.2007  31.12.2007 
Journal of Anatomy, Matti Airaksinen, 01.01.2007  31.12.2007 
Journal of Neurochemistry, Matti Airaksinen, 01.01.2007  31.12.2007 
Molecular and Cellular Neuroscience, Matti Airaksinen, 01.01.2007  31.12.2007 
BMC Neuroscience, Matti Airaksinen, 01.01.2008  31.12.2008 
Cell and Tissue Research, Matti Airaksinen, 01.01.2008  31.12.2008 
Journal of Biological Chemistry, Matti Airaksinen, 01.01.2008  31.12.2008 
Journal of Neurochemistry, Matti Airaksinen, 01.01.2008  31.12.2008 
Neuropsychopharmacology, Matti Airaksinen, 01.01.2008  31.12.2008 
Neuroscience, Matti Airaksinen, 01.01.2008  31.12.2009 
Trends in Neurosciences, Matti Airaksinen, 01.01.2008  31.12.2008 
Molecular Pain, Matti Airaksinen, 2009 
The Journal of Neuroscience, Matti Airaksinen, 2009 
Referee work for scientific journals, Matti Airaksinen, 2010 
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Eero Castrén ,  
Biological Psychiatry, reviewer, Eero Castrén, 01.01.2006  31.12.2007 
Brain Research, reviewer, Eero Castrén, 01.01.2006  31.12.2006 
Epilepsy Research, reviewer, Eero Castrén, 01.01.2006  31.12.2006 
European Journal of Neuroscience, reviewer, Eero Castrén, 01.01.2006  31.12.2006 
FASEB Journal, reviewer, Eero Castrén, 01.01.2006  31.12.2006 
Journal of Chemical Neuroanatomy, reviewer, Eero Castrén, 01.01.2006  31.12.2007 
Journal of Molecular Histology, reviewer, Eero Castrén, 01.01.2006  31.12.2006 
Journal of Neurobiology, reviewer, Eero Castrén, 01.01.2006  31.12.2006 
Journal of Neurochemistry, reviewer, Eero Castrén, 01.01.2006  31.12.2008 
Journal of Neuroscience Research, reviewer, Eero Castrén, 01.01.2006  31.12.2006 
Journal of Neuroscience, reviewer, Eero Castrén, 01.01.2006  31.12.2008 
Neurobiology of Disease, reviewer, Eero Castrén, 01.01.2006  31.12.2006 
Neuroscience Letters, reviewer, Eero Castrén, 01.01.2006  31.12.2006 
Neuroscience, reviewer, Eero Castrén, 01.01.2006  31.12.2006 
British Journal of Pharmacology, reviewer, Eero Castrén, 01.01.2007  31.12.2007 
European Neuropsychopharmacology, reviewer, Eero Castrén, 01.01.2007  31.12.2007 
Hippocampus, reviewer, Eero Castrén, 01.01.2007  31.12.2007 
International Journal of Neuropsychopharmacology, reviewer, Eero Castrén, 01.01.2007  31.12.2007 
Journal of Cell Biology, reviewer, Eero Castrén, 01.01.2007  31.12.2007 
Nature Reviews neuroscience, reviewer, Eero Castrén, 01.01.2007  31.12.2007 
Neuropsychopharmacology, reviewer, Eero Castrén, 01.01.2007  31.12.2008 
Proceedings of the National Academy of Sciences, USA, reviewer, Eero Castrén, 01.01.2007  31.12.2008 
Science, reviewer, Eero Castrén, 01.01.2007  31.12.2007 
BMC-Neuroscience, reviewer, Eero Castrén, 01.01.2008  31.12.2008 
Brain Structure and Function, reviewer, Eero Castrén, 01.01.2008  31.12.2008 
Epilepsy Research, reviewer, Eero Castrén, 01.01.2008  31.12.2008 
Experimental Brain Research, reviewer, Eero Castrén, 01.01.2008  31.12.2008 
Molecular Psychiatry, reviewer, Eero Castrén, 01.01.2008  31.12.2008 
Psychopharmacology, reviewer, Eero Castrén, 01.01.2008  31.12.2008 
Recent Patents on CNS Drug Discovery, reviewer, Eero Castrén, 01.01.2008  31.12.2008 
Biological Psychiatry, reviewer, Eero Castrén, 2010  …, United States 
Brain Structure and Function, reviewer, Eero Castrén, 2010  … 
Hippocampus, reveiwer, Eero Castrén, 2010  … 
Journal of Neuroscience, reviewer, Eero Castrén, 2010  …, United States 
Journal of Neuroscience, reviewer, Eero Castrén, 2010  …, United States 
Molecular Psychiatry, reviewer, Eero Castrén, 2010, United States 
Proceedings of the National Academy of Sciences, USA, reviewer, Eero Castrén, 2010  …, United States 
Science, reviewer, Eero Castrén, 2010  …, United States 
Pirta Hotulainen ,  
Referee work for scientific journals, Pirta Hotulainen, 2010 
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Henri Juhani Huttunen ,  
EMBO Journal, Henri Juhani Huttunen, 2006, United Kingdom 
American Journal of Pathology, Henri Juhani Huttunen, 2007, United States 
Brain, Henri Juhani Huttunen, 2009, United Kingdom 
Neurobiology of Disease, Henri Juhani Huttunen, 2009, United States 
Journal of Neurochemistry, Henri Juhani Huttunen, 08.2010 
Kai Kaila ,  
Reviewer / Journal of Neurophysiology, Kai Kaila, 1992  … 
Reviewer / NeuroImage, Kai Kaila, 1995  … 
Reviewer / Neuroscience, Kai Kaila, 1996  … 
Reviewer / Brain, Kai Kaila, 1998  … 
Reviewer / Amer. J. Physiology, Kai Kaila, 2000  … 
Reviewer / European Journal of Neuroscience, Kai Kaila, 2004  … 
Reviewer / Journal of Neuroscience, Kai Kaila, 2004  …, United States 
Reviewer / Journal of Physiology, Kai Kaila, 2004  … 
Reviewer / Neurobiology of Disease, Kai Kaila, 2004  … 
Reviewer / Neuropharmacology, Kai Kaila, 2004  … 
Reviewer / Bioorganic &amp; Medicinal Chemistry, Kai Kaila, 2005  … 
Reviewer / Cerebral Cortex, Kai Kaila, 2006  … 
Reviewer / Trends in Neurosciences, Kai Kaila, 2006  … 
Reviewer / Epilepsia, Kai Kaila, 2008  … 
Reviewer / Neuron, Kai Kaila, 2008  … 
Reviewer / Annals of Neurology, Kai Kaila, 2009  … 
Reviewer / Nature Clinical Practice, Kai Kaila, 2009  … 
Reviewer / Nature Medicine, Kai Kaila, 2009  … 
Reviewer / Nature Reviews Neurology, Kai Kaila, 2010  … 
Peter Blaesse ,  
Reviewer for Epilepsy Research, Peter Blaesse, 2008 
Reviewer for The European Journal of Neuroscience, Peter Blaesse, 2010 
Leonard Khirug ,  
Glia, Leonard Khirug, 2006, United States 
Journal of Cellular and Molecular Medicine, Leonard Khirug, 12.2009 
Minna Johanna Niittykoski ,  
PLoS ONE, Minna Johanna Niittykoski, 2010 
Sari Lauri ,  
Journal of Physiology, Sari Lauri, 2005  2010 
Cerebral Cortex, Sari Lauri, 2006  … 
Neuropharmacology, Sari Lauri, 2007  2011 
Synapse, Sari Lauri, 2008 
Brain Research, Sari Lauri, 2010  … 
Anna-Elina Lehesjoki ,  
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Annals of Neurology, Anna-Elina Lehesjoki, 01.01.2004  31.12.2006 
Annals of Medicine, Anna-Elina Lehesjoki, 01.01.2005  31.12.2005 
European Journal of Human Genetics, Anna-Elina Lehesjoki, 01.01.2005  31.12.2006 
Human Mutation, Anna-Elina Lehesjoki, 01.01.2005  31.12.2005 
Biochimica et Biophysica Acta, Anna-Elina Lehesjoki, 01.01.2006  31.12.2006 
Epilepsia, Anna-Elina Lehesjoki, 01.01.2006  31.12.2007 
Genes Brain &amp; Behaviour, Anna-Elina Lehesjoki, 01.01.2006  31.12.2006 
Human Molecular Genetics, Anna-Elina Lehesjoki, 01.01.2006  31.12.2006 
Journal of Medical Genetics, Anna-Elina Lehesjoki, 01.01.2006  31.12.2006 
Nature Genetics, Anna-Elina Lehesjoki, 01.01.2006  31.12.2006 
Epilepsy Research, Anna-Elina Lehesjoki, 01.01.2007  31.12.2007 
BBA-Molecular Cell Research, Anna-Elina Lehesjoki, 01.01.2008  31.12.2008 
Clinical Genetics, Anna-Elina Lehesjoki, 01.01.2008  31.12.2009 
European Journal of Human Genetics, Anna-Elina Lehesjoki, 01.01.2008  31.12.2009 
Neuropediatrics, Anna-Elina Lehesjoki, 01.01.2008  31.12.2009 
Epilepsy Research, Anna-Elina Lehesjoki, 01.01.2009  31.12.2009 
Nature Genetics, Anna-Elina Lehesjoki, 01.01.2009  31.12.2009 
Anne Polvi ,  
Verification of pro gradu for master's thesis, Anne Polvi, 04.2008  … 
Manuscript rewiever in "Epilepsy Research" journal, Anne Polvi, 2009 
Mentoring diploma work, Anne Polvi, 2009 
Matias Palva ,  
European Journal of Neuroscience, Matias Palva, 2007 
Journal of Neuroscience, Matias Palva, 2007  2009 
Journal of Neuroscience Methods, Matias Palva, 2007  2008 
NeuroImage, Matias Palva, 2007  2009 
Cerebral Cortex, Matias Palva, 2008  2009 
Clinical Neurophysiology, Matias Palva, 2008 
Neuroinformatics, Matias Palva, 2008 
Neuroscience, Matias Palva, 2008  2009 
Brain Research, Matias Palva, 2009 
Frontiers in Neuroinformatics, Matias Palva, 2009 
Journal of Cognitive Neuroscience, Matias Palva, 2009 
Satu Palva ,  
Peer-reviewer for grant application, Satu Palva, 2007  2010 
Peer-reviewer for scientific journals, Satu Palva, 2007  2010 
Pertti Panula ,  
Biochemical Pharmacology, Pertti Panula, 2006 
Peptides, Pertti Panula, 2006 
Proceedings of the National Academy of USA, Pertti Panula, 2006 
Acta histochemica, Pertti Panula, 2007  2008 
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Cell and Tissue Research, Pertti Panula, 2007  2008 
Histochemistry and Cell Biology, Pertti Panula, 2007  2008 
Journal of Neurochemistry, Pertti Panula, 2007  2008 
Neuroscience, Pertti Panula, 2007 
British Journal of Pharmacology, Pertti Panula, 2008 
European Journal of Neuroscience, Pertti Panula, 2008  2009 
European Journal of Pharmacology, Pertti Panula, 2008 
Journal of Chemical Neuroanatomy, Pertti Panula, 2008 
Brain Research, Pertti Panula, 2009 
Epilepsy Research, Pertti Panula, 2009 
Neurobiology of Disease, Pertti Panula, 2009 
Neuroscience, Pertti Panula, 2009 
Aquatic Toxicology, Pertti Panula, 19.12.2010 
Brain Pathology, Pertti Panula, 27.12.2010 
Brain Structure and Function, Pertti Panula, 10.12.2010 
British Journal of Pharmacology, Pertti Panula, 10.11.2010 
CNS neuroscience &amp; Therapeutics, Pertti Panula, 10.04.2010 
Frontiers in Neuroscience, Pertti Panula, 2010 
Journal of Chemical Neuroanatomy, Pertti Panula, 10.07.2010 
Journal of Comparative Neurology, Pertti Panula, 20.07.2010 
Journal of Neurochemistry, Pertti Panula, 10.05.2010 
Neuropathology and Applied Neurobiology, Pertti Panula, 2010 
Psychopharmacology, Pertti Panula, 01.11.2010 
Heikki Rauvala ,  
Molecular and Cellular Neuroscience, Heikki Rauvala, 01.01.2002  31.12.2008 
Journal of Cell Science, Heikki Rauvala, 01.01.2006  31.12.2008 
Journal of Molecular Histology, Heikki Rauvala, 01.01.2007  31.12.2007 
Journal of Cell Biology, Heikki Rauvala, 01.01.2008  31.12.2008 
Tomi Taira ,  
J. Neurosci, Tomi Taira, 2006 
J. Physiol., Tomi Taira, 2006 
Neuropharmacology, Tomi Taira, 2006  2008 
Neuroscience, Tomi Taira, 2006  2007 
Neuroscience Letters, Tomi Taira, 2006  2007 
Physiological Reviews, Tomi Taira, 2006  2007 
Synapse, Tomi Taira, 2006 
Journal of Neurophysiology, Tomi Taira, 2007  2008, United States 
Journal of Neuroscience Methods, Tomi Taira, 2007 
Neuromuscular Disorders, Tomi Taira, 2007 
Journal of Physiology, Tomi Taira, 2008 
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Assessment of candidates for academic posts 
Eero Castrén ,  
Examiner of the docent application, Eero Castrén, 2006, Finland 
Promotion of Agnieszka Balkowiec, Oregon Health &amp; Science University, USA, Eero Castrén, 2008, United States 
Promotion of Dr. Kobi Rosenbluhm, University of Haifa, Israel, Eero Castrén, 2008, Israel 
Promotion of Robert Lipsky, Uniformed Services University of the Health Sciences, USA, Eero Castrén, 2008, United States 
Promotion of Pierto Paolo Senna, The Scripps Research Institute, Eero Castrén, 2009, United States 
Promotion of Susana Cohen-Cory, University of California at Irvine, Eero Castrén, 2009, United States 
Promotion of Maribel Rios, Tufts University, Eero Castrén, 2010, United States 
Promotion of Simona Capsone, Scuola Normale Superiore, Pisa Italia, Eero Castrén, 2010, Italy 
Kai Kaila ,  
Promotion to professor, Univ. California, Davis, Kai Kaila, 2005, United States 
Gottfried Wilhelm Leibniz Prize, Kai Kaila, 2006, Germany 
Professor in General Neurophysiology, Univ. Heidelberg, Kai Kaila, 2008, Germany 
Promotion to professor, Univ. College London, Kai Kaila, 2008, United Kingdom 
ERC-2009-Advanced Grants, ERC European Research Council Executive Agency, Kai Kaila, 2009 
Promotion to professor, Univ. Oslo, Kai Kaila, 2009, Norway 
Sari Lauri ,  
Helsingin yliopiston tutkijatohtorin valinnat, Sari Lauri, 2007  2010, Finland 
Anna-Elina Lehesjoki ,  
Assessment of docentship of Sirpa Kivirikko, Anna-Elina Lehesjoki, 2005, Finland 
Assessment of Docentship of Maija Castren, Anna-Elina Lehesjoki, 2006, Finland 
Assessment of docentship of Hannes Lohi, Anna-Elina Lehesjoki, 2006 
Pertti Panula ,  
Examiner of the docent application, Pertti Panula, 15.02.2006, Finland 
Evaluation of candidates for professorship, Pertti Panula, 2009, United States 
Evaluation of a candidate for Volwiler Research Fellow, Pertti Panula, 2010  …, United States 
Evaluation of assistant professor for tenure, Pertti Panula, 2010, United States 
Heikki Rauvala ,  
Assessment of candidates for academic posts: Professor, Heikki Rauvala, 2006 
Assessment of candidates for academic posts: Professor, Heikki Rauvala, 04.01.2007 
Examiner of the docent application, Heikki Rauvala, 23.08.2007, Finland 
Examiner of the docent application, Heikki Rauvala, 15.10.2008 
Examiner of the docent application, Heikki Rauvala, 2009 
Examiner of the docent application of Runkuan Yang, Heikki Rauvala, 09.2010, Finland 
Tomi Taira ,  
Evaluation of candidates for professorship level post, Tomi Taira, 2006, Finland 
Examiner of the docent application, Tomi Taira, 2009, Sweden 
Membership or other role in review committee 
Matti Airaksinen ,  
Evaluation Panel of Research Council of Norway, Matti Airaksinen, 08.2006  09.2006, Norway 
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Grant evaluator, National University of Singapore, Matti Airaksinen, 2008, Singapore 
Grant evaluator, University of Marseille, Matti Airaksinen, 2008, France 
Kai Kaila ,  
Research Council of Norway, Kai Kaila, 1996  …, Norway 
Academy of Finland, Kai Kaila, 17.02.2005 
Reviewer / French National Research Agency (ANR), Kai Kaila, 2006  …, France 
Reviewer / European Research Council Executive Agency (ERCEA), Kai Kaila, 2008  … 
Reviewer / European Science Foundation (ESF), Kai Kaila, 2008  … 
Sari Lauri ,  
Helsingin Yliopiston 3-vuotiset tutkimusmäärärahat, Sari Lauri, 2010  … 
Pertti Panula ,  
ANR/INSERM, Pertti Panula, 2009, France 
ATIP: Creation D´Equipe, Pertti Panula, 2009, France 
Heikki Rauvala ,  
Member of an International Expert Panel Evaluating Research Projects for the Research Council of Norway, Heikki Rauvala, 2006, 
Norway 
Acting as a Evaluator for Research Council of Norway, Heikki Rauvala, 23.01.2007, Norway 
An Overall Evaluation of Research at Uppsala University, Evaluation panel 23, Heikki Rauvala, 07.05.2007  13.05.2007, Sweden 
Acting as an Evaluator for European Science Foundation (ESF), Heikki Rauvala, 10.01.2008 
Evaluator of the Research Council of Norway; Division for Science, Biology and Biomedicine, Heikki Rauvala, 03.05.2010, Norway 
Membership or other role in research network 
Eero Castrén ,  
Suomen Aivosäätiö, suunnittelutoimikunnan puheenjohtaja, Eero Castrén, 2004  2006, Finland 
EU FP6 Research Project: member, Eero Castrén, 2007  2010, Italy 
Member, Scientific advisory board, ERA-Net NEURON programme, EU, Eero Castrén, 2007  …, Belgium 
Member, Finnish Centre of Excellence in Molecular and Integrative Neuroscience Research, Eero Castrén, 2008  2013, Finland 
The Finnish Neurodegeneration Initiative: Chairman, Eero Castrén, 2010  …, Finland 
Kai Kaila ,  
Member of the Academy of Finland CoE in Molecular Neurobiology, Kai Kaila, 1999  2005 
Fellow of the Biocentrum Helsinki Organization, Kai Kaila, 2004  2013 
Member of Nordic CoE for Research in Water Imbalance Related Disorders, Kai Kaila, 2005  2009 
Cortex Training Network (Marie Curie EST), Kai Kaila, 01.01.2006  31.12.2009 
EU FP6 Integrated project EPICURE, Kai Kaila, 2007  2011 
Member of the Finnish CoE in Molecular and Integrative Neuroscience Research, Kai Kaila, 2008  2013, Finland 
Nordic-Russian postgraduate training network in neuroscience, Kai Kaila, 2009  2010 
Pertti Panula ,  
EU COST BM0804 EuFishBiomedNet, Pertti Panula, 24.06.2009  23.06.2013 
EU COST BM0806 Recent advances in histamine receptor H4R research, Pertti Panula, 09.04.2009  08.04.2013 
Integrative Fish Behavioral Neuroscience Network NORDFORSK, Pertti Panula, 01.09.2010  30.12.2012 
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Membership or other role in national/international committee, council, board 
Matti Airaksinen ,  
HY rahastot, apurahatoimikunta, Matti Airaksinen, 2008 
HY tiedesäätiö, Matti Airaksinen, 2009, Finland 
Telethon, France, Matti Airaksinen, 2009, France 
Eero Castrén ,  
Duodecim, apurahalautakunta, Eero Castrén, 2004  2006, Finland 
AMF France, Grant reviewer, Eero Castrén, 2005  2009, France 
ECNP Scientific Advisory Panel member, Eero Castrén, 2005  …, Netherlands 
Puheenjohtaja, Helsingin seudun bioteknologian koulutuksen ohjausryhmä, Eero Castrén, 2005  2006, Finland 
Swiss NSF, Grant reviewer, Eero Castrén, 2005  2009, Switzerland 
Thrasher Fund, Eero Castrén, 01.01.2006  31.12.2006, United States 
European Research Council, Eero Castrén, 20.08.2007 
NIMH, Review Committee member, Eero Castrén, 2007, United States 
National Institute of Mental Health, USA, Eero Castrén, 09.10.2007, United States 
ERC, Grant reviewer, Eero Castrén, 2009, Belgium 
FWF Austria, Grant reviewer, Eero Castrén, 2009, Austria 
McArthur Foundation, Grant reviewer, Eero Castrén, 2009, United States 
Wellcome Trust, Grant reviewer, Eero Castrén, 2009, United Kingdom 
ANR, France, Grant reviewer, Eero Castrén, 2010, France 
ASLA-Fulbright, Grant reviewer, Eero Castrén, 2010, United States 
Danish Council for Independent Research, arviointipaneelin jäsen, Eero Castrén, 28.05.2010, Denmark 
ERA-Neuron, Grant reviewer, Eero Castrén, 2010, Belgium 
ESF, Grant reviewer, Eero Castrén, 2010, France 
ESF, Reviewer pool member, Eero Castrén, 2010  …, France 
Israel Science Foundation, Grant reviewer, Eero Castrén, 2010, Israel 
Marie-Estelle Hokkanen ,  
Forskarskolans elevråd, Marie-Estelle Hokkanen, 01.01.2008  31.12.2008 
Pirta Hotulainen ,  
Board member in Brain research Society of Finland, Pirta Hotulainen, 01.01.2010  31.12.2010 
Henri Juhani Huttunen ,  
Tekes julkisen tutkimuksen projekti, johtoryhmän jäsen, Henri Juhani Huttunen, 04.2010  … 
Kai Kaila ,  
Reviewer / Swedish Natural Science Research Council, Kai Kaila, 1996  …, Sweden 
Finnish Graduate School of Neuroscience (FGSN), Kai Kaila, 1998  2011, Finland 
Reviewer / National Health and Medical Research Council (Australia), Kai Kaila, 1998  …, Australia 
Reviewer / Israel Science Foundation, Kai Kaila, 1999  …, Israel 
Reviewer / Wellcome Trust, Kai Kaila, 2000  …, United Kingdom 
Reviewer / Biotechnology and Biological Sciences Research Council (UK), Kai Kaila, 2001  …, United Kingdom 
Reviewer / Deutsche Forschungsgemeinschaft (SFB evaluations), Kai Kaila, 2004  …, Germany 
Finnish Graduate School of Neuroscience, Kai Kaila, 01.01.2006  31.12.2006 
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Institute of Biotechnology, University of Helsinki - Member of the Executive Committee, Kai Kaila, 2008  … 
Chairman/coordinator/grant holder of EACEA Tempus project, Kai Kaila, 14.01.2010  13.01.2013 
Leonard Khirug ,  
Society for Neuroscience, USA, Leonard Khirug, 1998  2009, United States 
Federation of European Neuroscience Societies, Leonard Khirug, 2003  2009, United States 
Human Frontier Science Program Organization, Leonard Khirug, 2008 
Sari Lauri ,  
Steering committee for the international Master's program in Neuroscience, member, Sari Lauri, 2009  2011 
Suomen Akatemian SIGHT 2009 työpajan jäsen, Sari Lauri, 15.09.2009, Finland 
Anna-Elina Lehesjoki ,  
Research Council for Health, Academy of Finland, Anna-Elina Lehesjoki, 2002  2006, Finland 
European Molecular Biology Organization (EMBO), Anna-Elina Lehesjoki, 2003  …, Germany 
Joint Committee of the Nordic Medical Research Councils NOS-M, Anna-Elina Lehesjoki, 2004  2009, Finland 
Nordisk samarbetsnämnd för medicinsk forskning, Anna-Elina Lehesjoki, 01.01.2004  31.12.2008 
Suomen akatemia, terveyden tutkimuksen toimikunta, Anna-Elina Lehesjoki, 01.01.2004  31.12.2009, Finland 
Suomen akatemia, terveyden tutkimuksen toimikunta, Anna-Elina Lehesjoki, 01.01.2004  31.12.2009, Finland 
The Finnish Genome Center, University of Helsinki, Anna-Elina Lehesjoki, 2005  2007, Finland 
Wellcome Trust, Anna-Elina Lehesjoki, 01.01.2005  31.12.2006 
Istitute of Molecular Medicine Finland (FIMM), Anna-Elina Lehesjoki, 2007  …, Finland 
Estonian Research Council, External reviewer, Anna-Elina Lehesjoki, 2009, Estonia 
External reviewer, Embo Fellowship, Anna-Elina Lehesjoki, 2009, Germany 
Suomen Akatemia, Nordiska samarbetsnämden för medicinsk forskning (NOS-M), Anna-Elina Lehesjoki, 2009, Finland 
Biotekniikan instituutti, johtokunta, Anna-Elina Lehesjoki, 2010  …, Finland 
Governance Committee of the International Genetics Consortium of the International League Against Epilepsy (ILAE), Anna-Elina 
Lehesjoki, 2010  … 
Institute of Biotechnology, University of Helsinki, Anna-Elina Lehesjoki, 2010  …, Finland 
Anna-Kaisa Anttonen ,  
Suomen Lääketieteellisen Genetiikan Yhdistys ry., Anna-Kaisa Anttonen, 24.03.2006  31.12.2006, Finland 
Maria Kousi ,  
Society for Neuroscience, USA, Maria Kousi, 2008, United States 
Mervi Kuronen ,  
Secretary of Societas biochemica, biophysica et microbiologica Fenniae, Mervi Kuronen, 01.08.2009  … 
Matias Palva ,  
Wellcome Trust, Matias Palva, 2007 
Wellcome Trust, peer-reviewer, Matias Palva, 2010 
Pertti Panula ,  
International federation of societies for histochemistry and cytochemistry, Pertti Panula, 01.02.2001  30.08.2008 
Suomen Histokemian ja solubiologian seura, Pertti Panula, 2001  2010, Finland 
European Histamine Research Society, Pertti Panula, 2005  2007 
Heikki Rauvala ,  
Board of Helsinki Graduate School in Biotechnology and Molecular Biology, Heikki Rauvala, 01.01.2006  31.12.2006, Finland 
Board of the Animal Facility of the University of Helsinki, Heikki Rauvala, 2006 
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Tomi Taira ,  
Helsingin yliopiston tiedesäätiö, Tomi Taira, 2006  2007, Finland 
Network of European Neuroscience Schools, Tomi Taira, 2006  2007 
Suomen Aivotutkimusseura, Tomi Taira, 2006  2009 
Suomen Akatemia, Tomi Taira, 2006, Finland 
TEMPUS Master´s program in Neuroscience, Univ. St Petersburg, Tomi Taira, 2006  2007, Russia 
CIMO, Tomi Taira, 2007, Finland 
Network of European Neuroscience Schools, Tomi Taira, 2010  2012 
Membership or other role in public Finnish or international organization 
Matti Airaksinen ,  
Finnish Brain Research Society, Matti Airaksinen, 01.01.2001  31.05.2009, Finland 
Koe-eläintoimikunta, Helsingin yliopisto, Matti Airaksinen, 01.01.2005  31.12.2006, Finland 
Eero Castrén ,  
Finnish Brain Research Society: chairman, Eero Castrén, 2003  2006, Finland 
Finnish Brain Research Society: Board member, Eero Castrén, 2006  2009, Finland 
HEBIOT -koulutusohjelman ohjausryhmä, Eero Castrén, 01.01.2006  31.12.2006, Finland 
Tieteellisen neuvoston jäsen, Eero Castrén, 2007  2009, Finland 
Kai Kaila ,  
Member of Societas Scientiarum Fennica (Suomalainen Tiedeakatemia), Kai Kaila, 2001  … 
Member of Academia Scientiarum Fennica, Kai Kaila, 2004  …, Finland 
Committee for research affairs, Kai Kaila, 2008  2013 
AVARA-varainhankintakampanja, Kai Kaila, 2009  … 
Leonard Khirug ,  
Societas Biochemica, Biophysica et Microbiologica Fenniae (Biobio), Leonard Khirug, 2006  2009, Finland 
Foreign Ministry of Finland, interview on the immigrant integration issues, Leonard Khirug, 2008 
Grant Application Evaluator, Leonard Khirug, 2010, France 
Sari Lauri ,  
Brain Research Society of Finland, Sari Lauri, 01.01.2004  31.12.2005, Finland 
Brain Research Society of Finland, member of the board, Sari Lauri, 2010  2011 
Heikki Rauvala ,  
Helsingin yliopiston koe-eläinkeskuksen johtokunta, Heikki Rauvala, 01.01.2007  31.12.2009, Finland 
Board Member of SHOK Planning Group, Heikki Rauvala, 01.01.2008  31.12.2008, Finland 
Membership or other role of body in private company/organisation 
Eero Castrén ,  
Novamass, Ltd, member of the board, Eero Castrén, 2007  2009, Finland 
Hermo Pharma, member of the Board, Eero Castrén, 2008  2009, Finland 
Hermo Pharma, member of the Scientific Advisory Board, Eero Castrén, 2009  …, Finland 
Henri Juhani Huttunen ,  
Hermo Pharma Oy, Henri Juhani Huttunen, 01.06.2008  31.12.2009, Finland 
Hermo Pharma Oy, Henri Juhani Huttunen, 01.06.2008  31.12.2010, Finland 
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Anna-Elina Lehesjoki ,  
Folkhälsanin tutkimuskeskus, Anna-Elina Lehesjoki, 2006  …, Finland 
Duodecim verkostovaliokunta, Anna-Elina Lehesjoki, 2007  2009, Finland 
Heikki Rauvala ,  
HermoPharma Oy, Heikki Rauvala, 01.01.2008  … 
Participation in interview for written media 
Henri Juhani Huttunen ,  
Tekniikka &amp; Talous, Henri Juhani Huttunen, 26.08.2008, Finland 
Kai Kaila ,  
Interview, Kai Kaila, 04.2009, Finland 
Interview / Ihminen on biologinen kone, Kai Kaila, 09.2009, Finland 
Heikki Rauvala ,  
Kansainvälinen aivoviikko, Heikki Rauvala, 14.03.2006, Finland 
Kansainvälinen aivoviikko, Heikki Rauvala, 13.03.2006  19.03.2006, Finland 
Tiedelehti: Neurotiede, Neurotieteen tutkimuskeskus, Heikki Rauvala, 22.03.2006, Finland 
Ari Rouhiainen ,  
Väitöstutkimus edistää tulehdustautien kliinistä määrittelyä, Ari Rouhiainen, 01.08.2008, Finland 
Tomi Taira ,  
Kirkko ja Kaupunki -lehti, Tomi Taira, 28.03.2007, Finland 
Haastattelu, Tomi Taira, 22.06.2010 
Participation in radio programme 
Eero Castrén ,  
Participation in radio programme, Eero Castrén, 2008 
Kai Kaila ,  
YLE Terveys, Radion tiedeuutiset, Kai Kaila, 05.10.2006 
Participation in radio programme, Kai Kaila, 12.02.2009 
Leonard Khirug ,  
Finnish State Radio YLE Mondo, Leonard Khirug, 01.01.2008, Finland 
Anna-Elina Lehesjoki ,  
Yle Radio 1, Anna-Elina Lehesjoki, 01.03.2007, Finland 
Intervju, Radio Folkhälsan, Anna-Elina Lehesjoki, 16.05.2008, Finland 
Radiohaastattelu, Yle Radio Yksi, Anna-Elina Lehesjoki, 21.01.2008, Finland 
Svergies Radio, Vetenskapsredaktion, Anna-Elina Lehesjoki, 16.04.2009, Sweden 
Participation in TV programme 
Matti Airaksinen ,  
Interview by the “Prisma” TV science program, broadcast Oct 3, 2007 in YLE1, Matti Airaksinen, 03.10.2007, Finland 
Kai Kaila ,  
Interview: YLE Teema, Kai Kaila, 2005 
Leonard Khirug ,  
Russian State Television, Leonard Khirug, 2008 
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Satu Palva ,  
Haastattelu Prisma TV ohjelmassa, Satu Palva, 19.03.2008, Finland 
Pertti Panula ,  
Significance of animal models in alcohol research, Pertti Panula, 06.10.2010 
Heikki Rauvala ,  
Prisma, Yle TV1, Heikki Rauvala, 19.09.2007, Finland 
Tomi Taira ,  
Yle Teeman tiededokumentti, Tomi Taira, 12.2007, Finland 
YLE Teema 'Tutkiva juttu', Tomi Taira, 09.12.2010, Finland 
Participation in interview for web based media 
Kai Kaila ,  
Tieteessä tapahtuu: Neurobiologia – Silta fysiikasta psykologiaan, Kai Kaila, 2006 
Keskosen ensimmäinen myssy mittaa aivojen toimintoja, Kai Kaila, 10.11.2010, Finland 
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Web of Science(WoS)-based bibliometrics of the RC’s publications data 1.1.2005-31.12.2010  
by CWTS, Leiden University, the Netherlands 
Research Group: Rauvala H 
Basic statistics 
Number of publications (P) 259 
Number of citations (TCS) 3,588 
Number of citations per publication (MCS)  13.89 
Percentage of uncited publications 12% 
Field-normalized number of citations per publication (MNCS)   1.64 
Field-normalized average journal impact (MNJS)   1.41 
Field-normalized proportion highly cited publications (top 10%)   2.03 
Internal coverage    .94 
 
Trend analyses 
 
MNCS 
 
THCP10 
 
MNJS 
Collaboration 
 
Performance (MNCS) by collaboration type 
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